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Stroke is the world's second leading cause of mortality, with a high incidence 
of morbidity. Oxidative stress, excitotoxicity, inflammation and apoptosis are 
cellular events regulating post-ischemic neuronal cell death, although the 
underlying molecular mechanisms are incompletely understood. Numerous 
neuronal membrane receptors are activated by endogenous ligands and may 
contribute to infarct development. Notch is a well-characterized membrane 
receptor involved in cell differentiation and proliferation and now shown to play 
a pivotal role in cell death during ischemic stroke. Blockade of Notch signaling 
by inhibition of γ-secretase, an enzyme that generates the active form of Notch 
(Notch intracellular domain, NICD), is neuroprotective following stroke. Many 
pieces of evidence of Notch-controlled cell death are in association with crucial 
hypoxic state eliciting transcription factors including Nuclear factor-κB        
(NF-κB) and Hypoxia inducible factor-1α (HIF-1α). Interestingly, Pin1, a 
peptidyl-prolyl isomerase that regulates p53 transactivation under stress, has 
been identified to promote the pathogenesis of ischemic stroke via Notch 
signaling.  Also, transcription factors, NF-κB and HIF-1α are p53 activation 
promoting entities widespread in many cellular models. Moreover, Notch in 
early neural progenitor cells selectively induces apoptosis by elevating levels 
of nuclear p53 and transactivation. The current study has investigated the 
interplay between Notch and p53 under ischemic stroke conditions. Using 
pharmacological inhibitors, it has been demonstrated that a NICD/p53 
interaction is involved in transcriptional regulation of genes downstream of p53 
and NICD to modify stroke severity.  Furthermore, p53 expression is 
maintained at a minimal level by mouse double minute 2 homolog (MDM2)-
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mediated ubiquitination and proteasomal degradation under normal conditions 
and can be stabilized by various cellular stresses. This study has demonstrated 
that the NICD/p53 interaction confers stability to p53 by rescuing it from 
MDM2-mediated ubiquitination. Here we provide the first evidence that Notch 
and p53 interact to activate apoptotic and neurodegenerative pathways during 
ischemic brain injury, and that suppression of Notch/p53 signaling ameliorates 
the disease process of ischemic stroke in a mouse model. Together, this study 
indicates Notch contribution to the pathogenesis of ischemic stroke by 
promoting p53 stability and signaling, and inhibition of the Notch/p53 complex 
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CHAPTER 1  
INTRODUCTION 
1.1 Stroke  
 
 
Before the Common Era, this condition was referred by the medical 
professionals as Apoplexy which originated with Hippocrates circa 400BC. The 
term ‘Apoplexy’ was used to refer the symptoms of paralysis and convulsions; 
an outcome of stroke occurrence. Upon the understanding the causes of stroke, 
the term ‘apoplexy’ faded way and the term ‘stroke’ was later followed in the 
medical setting and also described as Central Nervous System Infarction 
(Nilsen, 2010; Sacco et al., 2013).  Stroke is the second leading cause of 
mortality globally resulting in 6 million deaths each year approximately and a 
leading cause of long-term paralysis. A 12% increase in mortality is recorded in 
2012 since the beginning of the 21st century (Reeve, 2009; Organization, 2014; 
Walter Johnson, 2016).  
 
Stroke is a condition encompassing an acute decrease in blood flow to 
the brain tissue affecting the cellular physiology and neurological impairment. 
Typical characteristics of stroke is a sudden depletion of oxygen and glucose 
which are the energy driving essentials in cells and maintains the metabolic 
activity and physiological function of the brain. Stroke is clinically classified 
into two categories namely, hemorrhagic stroke and ischemic stroke according 
to the nature of an insult to the cerebral blood vessel network (Ahmad and 
Graham, 2010; Marti and Kunze, 2016).  
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1.1.1 Hemorrhagic stroke  
 
Hemorrhagic stroke accounts for 13-15% of the total stroke incidences 
and results from an impaired vessel rupturing and bleeding into the brain. The 
accumulated blood compresses the surrounding brain tissue. The condition is 
either presented as an intracerebral hemorrhage or a subarachnoid hemorrhage. 
Hemorrhagic stroke caused by impaired blood vessels are presented as the 
formation of the balloon at weak spots of blood vessels which ruptures to bleed 
into the brain known as an aneurysm or formation of an abnormal cluster of 
blood vessels known as arteriovenous malformation (AVM) (Gilgun-Sherki et 
al., 2002; Duan et al., 2016).  
 
1.1.2 Ischemic stroke 
  
 
Ischemic stroke contributes for 85-87% of all stroke cases. It is initiated 
by obstruction due to a blood clot at the arterial circuit supplying the brain 
tissues. The blood clot deprives the brain tissue from the supply of oxygen and 
nutrients, causing damage to the brain tissue (Bacigaluppi et al., 2010; Zhang et 
al., 2017). The obstruction will be instigated either by an embolic or a 
thrombotic occlusion of the cerebral artery. An embolic stroke occurs when a 
blood clot that forms elsewhere (embolus) due to cardiovascular condition 
breaks loose to travel and lodge in the arterial circuit of the brain causing a 
stroke whereas, a thrombotic stroke is a result of a blood clot (thrombus) 
developed at the clogged region of an arterial vessel already suffered from 
plaque deposits. Ischemic stroke is further classified as global ischemia and 
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focal ischemia (Bottiger et al., 1999). Global ischemia is characterized by severe 
obstruction of blood flow to either the entire brain organ or an extensive tissue 
portion of the brain. This condition is commonly observed in occlusion of 
coronary arteries associated with myocardial Infarction. On the contrary, focal 
ischemia is displayed with a specific brain region deprived of blood flow 
depending on the type of cerebral artery occluded either by an embolus or 
thrombus. The occlusion is observed either transiently or permanently and thus 
determines the extent of the damage. Focal ischemic stroke is by far, the most 
prevalent stroke condition reported (Lindblom et al., 2016; Sakai et al., 2016).   
 
There are various risk factors contributing to ischemic stroke and the 
direct risks include 1) Hypertension: A predicament which has 35-40% of cases 
at the disposition of suffering ischemic stroke making it the leading cause 
(Johansson, 1999; Kupferman et al., 2016; Smith et al., 2016), 2) Carotid artery 
stenosis: A condition in which the carotid arteries supplying blood to the brain 
suffers fatty plaque deposits in the interior walls, thus hardening and narrowing 
the blood vessels (Alagoz et al., 2016; Reznik et al., 2017), 3) High cholesterol: 
Presented with high intake of food with low density lipoprotein; the high levels 
of cholesterol leads to an increased risk of severe fatty plaque deposits in the 
arteries (Xing et al., 2016), 4) Diabetes mellitus: High glucose levels is reported 
as an independent risk factor and when presented with high blood cholesterol, 
overweight or high blood pressure increases stroke incidence (Yu et al., 2016; 
Arthur et al., 2017) and 5) Other indirect risk factors include existing 
cardiovascular disease, obesity and environmental habits such as, physical 
4 
 
inactivity, diet intake involving high saturated fat content, tobacco smoking and 
alcohol consumption (Jena et al., 2016; Laroche et al., 2016).  
 
Figure 1: Ischemic and hemorrhagic stroke brain 
There are two types of stroke, Hemorrhagic stroke and Ischemic stroke. The left 
hemisphere of the brain in the image shows a ruptured blood vessel bleeding into the 
tissues and resulting in a severe infarct. The right hemisphere of the brain in the image 
shows an ischemic clot occurring in the arteries supplying blood to the tissue. This 
blockade of blood flow will result in 2 distinct infarct region, the core receiving 
<10mL/100g/min of blood flow where the cells die immediately; the second region 
where there is still a collateral blood supply 10mL-50mL/100g/min, this region 
experience delayed cell death and is the salvageable area. (Adapted : bbc.com images) 
 
 
1.2 Ischemic stroke pathophysiology  
 
 
Brain tissue suffered an ischemic stroke damage encompasses an 
ischemic territory due to the formation of two regions, an ischemic core in the 
center and a surrounded ischemic penumbra also referred as peri-infarct region 
due to inadequate blood supply. The ischemic core will be found separated from 
the healthy tissues by the penumbra layer. The sizable extent of core and 
penumbra region will depend on the duration and severity of the cerebral blood 
flow obstruction. Following the blockage, the level of cerebral blood continuing 
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to perfuse the severed region regulates the advancement of ischemic core and 
penumbra size (Kumar et al., 2010; Ernst et al., 2015). To carry out a normal 
physiological function such as glycolysis and oxidative phosphorylation by 
utilizing oxygen and glucose supplied by an adequate blood flow, the rate of 
flow must sustain at 50mL/100g/minute. When the rate of flow drops to 
<10mL/100g/minute, an ischemic core develops making the core region suffer 
irreversible necrotic cell death and thus rendering the tissue metabolically, 
electrically and functionally inactive (Bisdas et al., 2004). The penumbra region 
develops due to the incomplete cessation of blood supply, which is an outcome 
of the intact collateral blood supply. The hypo-perfusion observed here will 
have a flow rate between 10mL and 50mL/100g/minute resulting in the tissue 
electrically and functionally affected yet metabolically active (Astrup et al., 
1981; Mehta et al., 2007). Unlike the cellular death observed in the ischemic 
core, the minimal oxygen and glucose availability drives a slow paced apoptotic 
cellular death to be manifested in ischemic penumbra making it the target for 
the therapeutic rescue of the severed tissue (Dharmasaroja et al., 2015; 
Ginsberg, 2016).  
 
Cerebral ischemia comprises of complex molecular and cellular 
mechanisms interconnected to trigger an apoptotic or necrotic cell death. The 
inadequate supply of glucose and oxygen during hypo-perfusion, an initial event 
in cerebral ischemia induces bio-energetic failure due to loss of ATP production 
(Vanlangenakker et al., 2008). Loss of ATP production impairs the ATP-
dependent proton pumps, voltage-gated ion channels, Na+/K+ ATPase pumps 
rendering the neurons and glial cells susceptible to an imbalance of ionic 
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gradient. This ionic imbalance results in extensive neuronal and glial membrane 
depolarization. The loss of ATP production further instigates the production and 
accumulation of lactate through anaerobic glycolysis (Padosch et al., 2001; 
Gusev and Skvortsova, 2002). The accumulated lactate leads to the acidic 
extracellular environment which regulates calcium permeable acid-sensing ion 
channels (ASICs) providing a path for predominantly Na+ and also low Ca2+ 
ions permeability.  The influx of Ca2+ thereby initiates the widespread cascade 
of events along with anoxic depolarization, excitotoxicity, oxidative stress and 
inflammation (Lust et al., 2002; Xiang et al., 2004; Xiong et al., 2004).   
 
 1.2.1 Neuronal depolarization and Excitotoxicity  
 
 
At homeostatic neuronal physiology, the synaptic transmission is either 
electric or chemical mode. The chemical mode of synaptic signaling is through 
amino acid neurotransmitters. Glutamate is a predominant neurotransmitter 
known to elicit action potential by activating the glutamate receptors such as 
AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) and NMDA 
(N-methyl-d-aspartic acid) at the post-synaptic terminal of the neuron (Gusev 
and Skvortsova, 2002; Brassai et al., 2015). These receptors are cationic 
channels, which allow Na+ and Ca2+ ions influx in the postsynaptic neurons 
triggering depolarization followed by an action potential. At basal physiology, 
the glutamate molecules found in the synaptic cleft is regulated through 
glutamate-glutamine cycle controlled by the astrocytes population. During 
ischemic insult, glutamate at the synaptic cleft is not converted to glutamine as 
a consequence of impaired homeostasis in astrocytes. The postsynaptic neurons 
7 
 
become susceptible to glutaminergic overstimulation, extensively activating the 
glutamate receptors and thereby enormous intra-cellular Ca2+ influx occurs. The 
depolarized neuron further amplifies the uptake of Ca2+ ions and release of 
glutamate (Sattler and Tymianski, 2000; Hinzman et al., 2015). If the ATP 
supply is not restored, Ca2+ ion influx regulated together by the activation of 
ASICs, glutamate receptors, impaired Na+/Ca2+ exchanger and Ca2+-ATPase 
pump will result in a cascade of nuclear and cytoplasmic events leading to an 
adversity known as  excitotoxicity (Kristian and Siesjo, 1998). In addition, the 
influx of Na+ ions into neurons develops an osmotic movement of water from 
extracellular matrix through aquaporin, resulting in swelling of the cell and 
edema in brain tissue (Iijima, 1998; Jarvis et al., 2001; Anderson et al., 2005).  
 
1.2.2 Oxidative stress  
 
 
Disrupted calcium homeostasis initiates to multiple mechanisms to 
damage the neurons and glial cells.  Ca2+ ions are a powerful activator of 
Mitochondria-mediated oxidative stress. Mitochondria are the mastermind of 
metabolism and mitochondrial glycolysis. The mitochondrial inner membrane 
is the platform of oxidative phosphorylation through electron transport chain 
(ETC) with the use of ATP synthase (Sims and Muyderman, 2010; Chehaibi et 
al., 2016). During cerebral ischemia, the excess Ca2+ ion influx is up taken by 
the calcium uniporter, MCU/MCUR1 of the mitochondrial matrix. The 
abnormal mitochondrial accumulation of Ca2+ ions will form the calcium 
precipitates affecting the transmembrane potential and perturbing the electron 
transport chain (Kristian and Siesjo, 1998; Ying and Padanilam, 2016). 
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Perturbed electron transport chain results in a premature electron leakage to 
oxygen to produce superoxide (O2
-), an anionic free radical (Sims and 
Muyderman, 2010; Murphy, 2016; Ying and Padanilam, 2016). Numerous Ca2+ 
mediated path contribute to the production of superoxide (O2
-). Ca2+ mediated 
protein Kinase C (PKC) activation generates O2
-, through nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase (Perez-Pinzon et al., 2005). 
Production of prostaglandins and leukotrienes through Ca2+ induced 
Phospholipase A2 (PLA2), activation generates O2
- as well. O2
- along with other 
reactive oxygen species (ROS) such as hydroxyl anionic-radical (OH-), 
hydrogen peroxide (H2O2) and peroxynitrite (ONOO
-) induces oxidative stress 
(Kristian and Siesjo, 1998; Ste-Marie et al., 2000; Lushchak, 2014; Pisoschi and 
Pop, 2015). Oxidative stress is a predominant cause of tissue damage by 
targeting the essential cellular organelles. Cellular damage is elicited by the 
generated ROS stealing electrons and resulting in oxidation of the cellular 
components nucleic acids, proteins and lipids (Zitnanova et al., 2016). 
Consequently, a multitude of pathway cascade including nuclear factor kappa 
B (NF-κB), mitogen-activated protein kinases (MAPKs) and c-Jun-N-terminal 
kinase (JNK) known to modulate caspase-mediated apoptosis are activated 
(Manzanero et al., 2013). ROS damages the rich calcium storage site, 
Endoplasmic reticulum mediating excessive calcium release in response to an 
amplified initial calcium insult a process termed calcium-induced-calcium-
released (CICR). In turn, the cumulative calcium insult perturbs mitochondria 
facilitating the release of apoptosis-mediating factors (Kristian and Siesjo, 




In addition to triggering reactive oxygen species, calcium influx also 
activates the catabolic enzymes, endonuclease, and calpain. Endonuclease is a 
nuclear protease cleaving DNA upon activation generating DNA breaks, which 
can trigger an apoptotic cascade (Hayashi et al., 1999; Cui et al., 2000; Saki and 
Prakash, 2016). Calpains are calcium activated non-lysosomal neutral 
proteases, located in cytoplasm performing hydrolysis of proteins to an inactive 
state. These calpains-inactivated functional proteins include cytoskeletal 
proteins such as actin, tubulin, and spectrin; membrane proteins including 
glutamate receptors and ryanodine receptors; anti-apoptotic B-cell lymphoma 2 
(Bcl-2) family of proteins such as B-cell lymphoma-extra large (Bcl-XL) and 
Bcl-2 (B-cell lymphoma 2); pro-apoptotic Bcl-2 family of protein apoptosis-
inducing-factor (AIF). Unlike other functional proteins, hydrolysis of AIF 
renders it active in its truncated form. Consecutively, calpains can trigger the 
cathepsin-mediated proteolysis of cellular proteins and together with calpains 
mediated proteolysis contributes to cellular demise through necrosis 





Inflammation is an innate immune reaction to damage and infection 
known to revive the host from cellular insult. However, inflammation is a 
characteristic event in the ischemic reperfusion injury as the inflammatory 
pathway in ischemic brain damage contributes to the exacerbation of the injury. 
As a result of the ischemic damage, dissociated cellular debris from the necrotic 
cell death of ischemic core region functions as ligands known as damage 
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associated molecular patterns (DAMPs) which can trigger danger signal by 
activating cellular pattern recognition receptors (PRRs).  Such PRRs include 
cell surface receptors including toll-like receptors (TLRs) TLR2 and TLR4; 
receptor for advanced glycation end products (RAGE); c-type lectin Mincle 
receptor; IL-1 receptor1 (IL-1R1). Together these receptors will elicit an 
inflammatory signaling pathway upon specific DAMP-interaction in neurons, 
microglia, astrocytes and endothelial cells (Ishikawa et al., 2005; Kigerl et al., 
2014; Li et al., 2014; Okun et al., 2014).  
 
These activated cells secrete the resultant inflammatory functional 
proteins known as pro-inflammatory cytokines including tumor necrosis factor-
α (TNF-α); interleukins (IL)-1β, IL-16 and IL-18. The predominant signaling 
pathways, mitogen-activated protein kinase (MAPK) and nuclear factor kappa 
beta (NF-κB) mediated intracellular multi protein complexes formation termed 
inflammasomes, promotes the pro-inflammatory cytokines release (Allan and 
Rothwell, 2001; Fann et al., 2013a; Arumugam et al., 2016).  The released pro-
inflammatory cytokines promote immune cells infiltration by inducing various 
cell adhesion proteins in endothelial cells, platelets and leukocytes. The 
expression of cell adhesion proteins including, intercellular adhesion molecule-
1 (ICAM-1), selectins, integrins and vascular cell adhesion molecule (VCAM) 
are regulated by the pro-inflammatory cytokines which have a vital role in 
facilitating immune cells infiltration including monocytes/macrophages and 
neutrophils at the site of ischemic territory during reperfusion (Arumugam et 




Consecutively, in addition to pro-inflammatory cytokines released by 
neurons and glial cells, monocyte chemo-attractant protein-1 (MCP-1) is 
secreted  initiating the leukocytes migration to the ischemic territory, a process 
called chemotaxis. The infiltrated immune cells additionally contributes to the 
ischemic reperfusion injury by releasing various cytotoxic components such as, 
nitric oxide (NO) from inducible nitric oxide synthase (iNOS), NADPH 
oxidase-derived ROS, pro-inflammatory cytokines, matrix metalloproteinases 
(MMPs) which particularly affect the blood brain barrier (BBB) and 
extracellular matrix exacerbating brain damage and edema promoting more 
neuronal and glial cell demise in addition to the cell death caused by initial 
ischemic event (Dimitrijevic et al., 2006; Yang et al., 2007; Liu and Mu, 2014). 
Further, leukocyte recruitment is mediated by the complement system, an 
inevitable event involved in ischemic reperfusion injury. A characteristic event 
is the formation of membrane attack complex (MAC) in neurons and glial cells, 
mediated by anaphylatoxins, including C1, C3a and C5a. This complement 
cascade causes cell lysis and results in damage to tissue as well (Arumugam et 







Figure 2: Cellular events of ischemic stroke pathophysiology 
Ischemic stroke initiates major mechanisms affecting the neurons. The initial 
depletion of blood flow restricts the availability of glucose and oxygen leading 
to decreased ATP production through glycolysis and oxidative phosphorylation. 
Alternatively, anaerobic glycolysis starts accumulating lactic acid resulting in 
acidotoxicity mediated Na+ influx through ASICs and ATP-Na+ pumps resulting 
in edema due to osmotic movement of water which leads to necrosis. The failing 
of ATP-pumps causes anoxic depolarisation and the voltage-gated Ca2+ 
channels allow the influx of ions inducing uncontrolled glutamate release. The 
glutamate transporters are impaired leaving the accumulated glutamate at 
synaptic cleft to continue to sensitize the Ca2+ channels resulting in 
excitotoxicity. Up-regulated Ca2+ ions mediate mitochondrial proteins release 
to execute apoptosis and in parallel triggers degradative enzymes and 
production of ROS which degrades key cellular proteins such as, membrane 
proteins, cytoskeletal proteins; lipids and nucleic acids contributing to necrosis 
and inflammatory release. The released inflammatory mediators recruit immune 
cells and activate glial cells at the site of entry and as a positive feedback cycle, 
ROS and cytokines released by glial cells damage the other neighboring 
neurons. (Adapted : Dirnagl et al., 1999) 
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The cellular events of pathophysiology including neuronal 
depolarization mediated excitotoxicity, oxidative stress and inflammation 
together trigger the different mechanism of cell death. Programmed cell death 
where the cellular bodies are highly maneuvered for an organized disposal and 
a non-programmed cell death culminated by the release of cellular content into 
the extracellular matrix without organized packaging. The cell death mechanism 
is further categorized as a caspases-dependent mechanism and caspases-
independent mechanism.  Caspases are protease enzymes cysteine-
dependent aspartate-directed playing a vital role in cleaving cellular proteins at 
c-terminal after aspartate residue during the programmed cell death pathway. 
Study of embryonic development in Caenorhabditis elegans revealed the amino 
acid sequence of CED-3 sharing the functional similarity with a mammalian 
version of protease known for mature IL-1β conversion to its active form and 
was named ‘caspase-1’ leading to the subsequent discovery of a family of these 
proteases. Caspases exist in the cytosol as inactive pro-forms and are activated 
by other caspases by proteolytic cleavage. Caspases are broadly categorized 
either as apoptotic caspases including Caspase-2, -3, -6, -7, -8, -9 and -10 or 
inflammatory caspases such as, Caspase-1, -4, -5, -13 and -14; murine homolog 
-11 for -4 and -5; murine homolog -12 for -13 and -14 (Nicotera, 2002; Fink 





























































































































































































































































































































































































1.3.1 Necrosis  
 
 
Necrosis is a non-programmed, accidental cell death resulting from 
environmental perturbation, which is morphologically and mechanistically 
differentiated from the highly programmed apoptotic pathway by its 
characterized presence of dead tissues or cells unlike the bulging of apoptotic 
vesicles. Necrosis is also termed oncosis derived from ‘oncos’ meaning 
swelling. Necrotic cell death is characterized by acute calcium influx elicited 
excitotoxicity, the release of excitotoxins, stored cellular energy depletion, 
oxidative stress mediated chromosomal DNA breaks and disintegration of 
membrane pumps (Nicotera and Lipton, 1999; Snider et al., 1999; Lossi et al., 
2015). Necrosis involves process demanding uncontrolled cellular ATM 
consumption resulting in energy depletion in response to severe DNA energy. 
DNA strand breaks activate nuclear enzyme such as, Poly (ADP-ribose) 
polymerase (PARP) which during a moderate DNA damage facilitates DNA 
repair through the addition of poly (ADP-ribose) to a variety of nuclear proteins. 
During ischemic stroke, chromosomal DNA experiences acute insult, 
nicotinamide adenine dinucleotide (NAD) coenzyme dependent PARP catalysis 
depletes the coenzyme reserve promoting ATP-dependent excess NAD 
synthesis (Murphy, 1999; Pieper et al., 1999; Walisser and Thies, 1999; Cho, 
2014). In addition, necrotic cell death also include cyclophilin-D (Cyp-D) 
forming mitochondrial permeability transition pore (MPTP) to mediate 
necrosis, calpains-mediated Cathepsins C and D triggered lysosome-
destabilizing agent L-leucyl-L-leucine methyl ester (LLOMe) drives proteolytic 
cascade in lysosomal-mediated necrosis (LMN) (Galluzzi et al., 2014; Brojatsch 
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et al., 2015; Ying and Padanilam, 2016). Tumor necrosis factor-α (TNF-α) along 
with its cognate receptor TNFR1 mediates RIP1 kinase mechanism of cell death 
which is similar to the cell death lead mitochondrial protein, AIF effected 
chromatinolysis. Cumulatively, TNF-α mediated and AIF regulated unique cell 
death  pattern is recently defined ‘necroptosis’ describing the coalescence of 
apoptosis and necrosis or rather an orderly regulation of necrosis (Majno and 
Joris, 1995; Murphy, 1999; Zaremba, 2000; Hallenbeck, 2002; Lossi et al., 





Pyroptosis is a morphologically distinct form of programmed and a 
highly inflammatory mode of cell death, a response that occurs due to pathogen 
associated molecular patterns (PAMPs) and DAMPs interacting PRRs signaling 
mechanism. The term ‘pyroptosis’ is of greek origin ‘pyro’ and ‘ptosis’ meaning 
fire and falling respectively denoting its characteristic feature in releasing 
inflammatory mediator and triggering a chain of the inflammatory process in 
the neighboring cellular population (Fink and Cookson, 2005). In an ischemic 
stroke, this process is characterized by inflammation triggered through DAMPs 
from tissue injury resulting in a release of inflammatory mediators in the 
extracellular region.  Pyroptosis is predominantly a caspase-1 dependent 
mechanism which has been described in neurons, monocytes, macrophages and 
dendritic cells. Caspase1 activation involves the formation of inflammasome 
complex of proteins including NLRP-1, NLRP-3, NLRC4 and AIM-2 as well 
as ASC leading ultimately to the functional outcome of the pyroptotic pathway 
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involving the release of pro-inflammatory cytokines such as IL-1beta and IL-
18. Initial activation of Caspase-1 leads to the removal of CARD domain by 
cleavage at the specific site resulting in the p10 and p20 catalytic domain 
fragments separation. (Fink and Cookson, 2005; Miao et al., 2011; Chang et al., 
2013; Fann et al., 2013a; Fann et al., 2013b; Adamczak et al., 2014; Sangiuliano 
et al., 2014). 
 
Pyroptosis is characterized by the release of pro-inflammatory mediators 
in the extracellular environment due to pores formed on the plasma membrane 
and rapid rupture mediated by cleaved capase-1 through an unknown 
mechanism. The pores are of diameter 1.1–2.4 nm which eventually 
disintegrates the membrane ionic gradient pumps, allowing an excessive influx 
of cationic ions facilitating the osmotic movement of water through aquaporins 
resulting in swelling of the cell. The swelling results in large spherical 
protrusions in the membrane making it detach from the cytoskeleton structure 
(Fink and Cookson, 2006).  Cleaved caspase-1 mediated pyroptosis is also 
characterized by chromosomal DNA breaks cleaved by caspase-1 dependent 
endonucleases (Walsh et al., 2011).  Cleaved caspase-1 has been described to 
inactivate enzymes including fructose-bisphosphate aldolase, α-enolase, 
glyceraldehyde-3-phosphate dehydrogenase and pyruvate kinase of the 
glycolysis pathway thus leading to bioenergetic failure (Barrington et al., 2016; 
Yuan et al., 2016).  Pyroptosis executes the cell death by osmotic lysis in the 
acute scenario, chromosomal DNA cleavage by a chronic or delayed stress 
which will consecutively lead to an apoptotic cell death, another form of 
programmed caspase-dependent cell death. Moreover, cleaved caspase-1 was 
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found to activate both executioner caspase-3 and caspase-7, and Bid by cleaving 
to its truncated form (Bergsbaken et al., 2009; Fann et al., 2013a; Shi et al., 
2016).  
 
In addition to the caspase-1 promoted canonical pyroptotic pathway, 
caspase-11 is involved in the non-canonical pathway of pyroptosis although the 
mechanism behind remains to be well-understood.  Caspase-11 is the murine 
homolog for human caspase-4 and caspase-5 and its cleaved form has been 
described to activate executioner caspase-3 and caspase-7 to induce apoptotic 
cellular death. Hence, these events together cause lysis of the affected neuronal 
cell in ischemic stroke either through the canonical caspase-1 pathway or 
through caspase-11 (Bergsbaken et al., 2009; Vigano and Mortellaro, 2013; Shi 





Apoptosis is an instructive energy-dependent mechanism, genetically 
embedded and involves execution of a cascade containing a series of 
components and when activated elicits exclusion of cells through fragmented 
membrane-bound cellular bodies otherwise termed ‘apoptotic blebs’. The term 
‘apoptosis’ is of Greek origin denoting ‘falling off’ which connotes the 
morphological characteristic feature observed during atrophy of tissue and 
organ development paradigm to dispose of redundant cells with the purpose to 
promote healthy cell turnover; hence, perceptibly a deregulation in apoptosis 
initiation will be associated with deformities and abnormalities. The cellular 
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morphology associated with this phenomenon involves dismantling of cell 
organelle by nuclear and cytoplasmic condensation from within the cell 
packaged into apoptotic bodies in an organized way and unlike other modes of 
cell death, minimizes damage and disruption to neighboring cells. An early 
process of apoptosis is cell shrinkage characterized with condensed cytoplasm 
and tightly packed organelles and pyknosis as a result of chromatin 
condensation, the landmark feature in apoptosis (Kerr et al., 1972; Hacker, 
2000). In the later steps, packaged apoptotic bodies are phagocytized by 
neighboring cells through endocytosis mechanism following distinct steps 
involving, invagination of the plasma membrane, engulfment of phagocyte 
vesicle, internalization and fusion of the phagocyte vesicle with lysosomes 
forming phagosomes inside which the apoptotic bodies are degraded. Besides 
maintaining a healthy homeostasis, apoptosis is an inevitable process during 
immune reactions, noxious agents or tissue injury and cellular impairment 
situation (Hiramine, 1997; Kerr, 2002). During ischemic stroke, penumbra 
region undergoes apoptotic death few hours and days after the blood flow 
obstruction, unlike the core region, which is predominantly featured with acute 
necrotic death. Hence, penumbra befits the salvageable region and can be a 
therapeutic option for rescue. The situation leading to apoptotic death 
remarkably explains the cells inability to meet the demand of nutrients for the 
cellular machinery of metabolism and likely tipped the cellular balance towards 
death (Porn-Ares et al., 1998; Charriaut-Marlangue, 1999). The important 
family of proteases executing this phenomenon is caspases existing in an 
inactive ‘pro’ state. As mentioned earlier, the apoptotic caspases are Caspase-2, 
-3, -6, -7, -8, -9 and -10 which could be further classified as initiator caspases 
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(caspase-2, -8, -9 and -10) having long domains dimerize through the death 
effector domain or caspase recruitment domain motifs; executioner caspases 
(caspase-3, -6 and -7) containing relatively shorter domains which executes the 
cell death process by cleaving the cellular substrates. Apoptosis regulators 
although not successful has emerged as the targets for therapeutic methods to 
modulate the cellular death decision (Hengartner and Horvitz, 1994; Kumar, 
1995; Whyte and Evan, 1995) 
    
 
Apoptosis is subdivided into 2 pathways including, intrinsic mechanism 
carried out through calcium and ROS generated from mitochondrial oxidative 
stress; and extrinsic mechanism executed by ligand-receptor mediated both 
directly and through mitochondrial downstream signaling respectively (Mattson 
et al., 2000; Charriaut-Marlangue, 2004; Fischer and Schulze-Osthoff, 2005). 
 
1.3.3a Intrinsic pathway of apoptosis 
 
ROS generation and effect on mitochondrial activity 
 
 
ROS contributes majorly for tissue injury after cerebral ischemia. As 
explained earlier, the reactive oxygen species are O2
-, H2O2, OH
-. The 
production of the ROS is controlled by xanthine oxidase, mitochondrial electron 
transport chain, arachidonic acid, NADPH oxidase, endogenous antioxidants 
such as superoxide dismutase (SOD), manganese superoxide dismutase 
(MnSOD), glutathione peroxidase, glutathione and catalase. Perturbed electron 
transport chain is a major event giving rise to ROS. Events like excitotoxicity 
(glutamate), and Ca2+ overload after cerebral ischemia and during reperfusion are 
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the triggering mechanism to develop ROS accumulation (Sugawara and Chan, 
2003; Perez-Pinzon et al., 2005; Loh et al., 2006; Miller et al., 2006; Sims and 
Muyderman, 2010; Murphy, 2016; Ying and Padanilam, 2016). O2
-, OH-, H2O2 
and highly toxic molecule, peroxynitrite (ONOO-) generated from interaction 
of O2
- with NO causes tissue damage during cerebral ischemia, either destroying 
cellular proteins, lipids and DNA by direct contact or indirectly disrupting the 
normal cellular signaling and gene regulation. Collectively, ROS can trigger 
either the mitochondrial caspase-dependent or mitochondrial and non-
mitochondrial caspase-independent cascade of apoptosis characterized by 
altered Bcl-2 family proteins (Kristian and Siesjo, 1998; Morita-Fujimura et al., 







Ca2+ entry regulated intrinsic mechanism includes the events which are 
described earlier, such as excitotoxicity and oxidative stress. As mentioned 
before, the onset of ischemic stroke limits the delivery of oxygen and glucose 
due to blood supply obstruction impairing the bioenergetics required to maintain 
homeostasis. The rapid imbalance of bioenergetics can lead to membrane 
potential loss and depolarization of the cells causing excitotoxicity. These 
mechanisms are carried out by the presence of voltage–gated channels present 
at the cell surface (Dirnagl et al., 1999; Mergenthaler et al., 2004; Jeanneret et 
al., 2016; Radak et al., 2016). Various voltage-gated channels are activated upon 
the binding of glutamate amino acid, released by the pre-synaptic cells into the 
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synaptic cleft of the extracellular space. The most-widely studied channels are 
the receptors opened by accumulated glutamate to operate the cationic inflow 
into the post-synaptic junction neuron. Ionotropic receptors like NMDA and 
AMPA gate the entry of Ca2+ ions under glutamate influence increasing the 
intracellular Ca2+ concentration. In addition, acid-sensing ion channels (ASICs) 
and transient receptor potential channels (TRP) triggered by acidosis can act as 
a major contributor of neuronal apoptosis through mediating  Na+ ions 
permeability and to a lesser degree of Ca2+ ions. The two subunits of ASICs, 
ASIC1a and ASIC2a has a contributory role in cerebral ischemia.  The cationic 
channels mediated Na+ and Ca2+ ions influx in the postsynaptic neurons triggers 
depolarization and together with NMDA and AMPA elicits an action potential. 
The depolarized neurons further amplify the uptake of Ca2+ ions and release of 
glutamate resulting in a cascade of nuclear and cytoplasmic events leading to 
an excitotoxic adversity.  (Kristian and Siesjo, 1998; Verkhratsky and Petersen, 
1998; Horn et al., 2001; Liu et al., 2007; Simard et al., 2007; Miller et al., 2014).   
 
 




As an organelle responsible for maintaining the Ca2+ homeostasis 
mitochondria functions as a buffering and a storage system of the intracellular 
calcium and in regulating physiological stimulation upon Ca2+ signals. 
Mitochondrial sensing of the increased cytoplasmic Ca2+ takes place by the 
negative membrane potential developed across the inner mitochondrial 
membrane. In addition to Ca2+ clearance, the inner membrane also participates 
in the Ca2+ ions elevation when required to regulate Ca2+ mediated function in 
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the cytoplasm. The mitochondrial proteins involved in the regulation of the 
calcium uptake include a complex of proteins forming channels called the 
uniporter along with the assistance of voltage present across the inner membrane 
due to the protons generated by the respiratory chain. Excessive cytoplasmic 
Ca2+ is up-taken by the ion-conducting pore forming calcium uniporter, 
mitochondrial calcium uniporter (MCU) in the presence of 
mitochondrial calcium uniporter regulator 1 (MCUR1) interaction at the inner 
mitochondrial matrix. Consequently, mitochondrial protein MICU1 is identified 
as an integral part of MCU/MCUR1 complex regulating the mitochondrial Ca2+ 
threshold for intracellular Ca2+ uptake; functioning as a gatekeeper ensuring the 
MCU-mediated Ca2+ uptake kinetic to be intact; and prevents mitochondrial 
Ca2+ overload associated stress. The imbalance in the mitochondrial kinetics is 
associated with the release of ROS (Verkhratsky and Petersen, 1998; 
Mallilankaraman et al., 2012b; Mallilankaraman et al., 2012a; Manzanero et al., 
2013; Kaufman and Malhotra, 2014).  
 
In cerebral ischemia, several events occur in mitochondria unfavorable 
for the survival of neurons and centrally regulates the neuronal apoptosis 
through release of various pro-apoptotic proteins. The glutamate receptors 
sensitization results in a large volume of Ca2+ influx triggering endoplasmic 
mediated Ca2+-induced Ca2+ release (CICR). Following an increase in Ca2+ 
levels activation of Ca2+ dependent protease, calpains occur which hydrolyze 
specific proteins including cytoskeletal, Membrane, and several Bcl-2 family of 
proteins located within cytoplasm and mitochondria. Calpains inactivate anti-
apoptotic mechanism by truncating proteins including Bcl-2 and Bcl-XL and on 
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the contrary, Calpains activate pro-apoptotic mechanism by truncating Bid and 
AIF. Bid, predominantly prevailing in the cytoplasm when activated to tBid 
translocates to mitochondria targeting the outer membrane and simultaneously 
induces a conformational change in proteins such as Bak, Bax, Bad, and Bcl-
XS activating its proapoptotic property. AIF, originally present in the inner 
mitochondrial membrane upon truncation to tAIF can translocate to nucleus 
along with endonucleaseG (EndoG) to potentiate chromatinolysis (Folbergrova 
et al., 1992; Verkhratsky and Petersen, 1998; Plesnila et al., 2001; Plesnila et 
al., 2002; Sugawara et al., 2004; Culmsee et al., 2005; Manzanero et al., 2013; 
Curcio et al., 2016; Potz et al., 2016).  
 
 
Bad attains its activated state through dephosphorylation and 
translocates to mitochondria from the cytosol forming dimers with Bcl-XL, an 
anti-apoptotic protein in regard to inhibiting its anti-apoptotic role. The 
inhibition of Bcl-XL and Bcl-2 is also carried out by Puma, a cytosolic pro-
apoptotic protein. Subsequently, pro-apoptotic Bax which is inhibited by anti-
apoptotic proteins Bcl-XL and Bcl-2 gets released following Bad and Puma 
interaction with both the inhibitory proteins. Following release from inhibition, 
Bax translocates to the outer mitochondrial matrix in association with Bak can 
form pores facilitating the release of cytochrome-C (Cty-C) from the 
mitochondrial intermembrane space (Fujimura et al., 1999; Antonsson et al., 






Caspase cascade dependent apoptosis 
 
 
Caspase cascade is regulated by the release of pro-apoptotic proteins 
from the intermembrane space of the mitochondria through the transition pores. 
Cyt-C, Smac/DIABLO and Omi/HtrA2 are the prominent pro-apoptotic agents 
released to activate the caspase cascade. The released Cyt-C in the cytoplasm is 
bound to form the apoptosome complex by clustering with procaspase-9 and 
apoptotic protease activating factor 1 (Apaf-1). The formation of apoptosome is 
the triggering event of procaspase-9 activation by cleavage mechanism making 
caspase-9 the initiator of Cyt-C-dependent caspase signaling. Meanwhile, the 
enhanced apoptosome formation is facilitated by the mitochondrial release of 
Smac/DIABLO and Omi/HtrA2 which binds to the inhibitors of apoptosis 
(IAPs) (Jayanthi et al., 2004). Enhanced apoptosome formation is the 
characteristic apoptotic feature shortly after the onset of ischemic stroke and a 
limiting step for procaspase-3 activation. Various neuroprotective compounds 
have been studies targeting this complex of proteins to rescue the cells 
experiencing ischemic stress. The activated procaspase-3 in a truncated form 
known as an executioner caspase, cleaved-caspase-3 and so far identified as a 
key mediator of apoptosis. An up-regulated activation of caspase-3 is observed 
shortly after the initiation of stroke extending during reperfusion duration as 
well (Asahi et al., 1997; Namura et al., 1998; Fujimura et al., 1999; Rami et al., 
2003; Cao et al., 2004). 
 
Major cellular events which take place by the executioner, caspase-3 are 
cleavage of substrate proteins.  PARP, a nuclear enzyme activated by DNA 
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strand breaks during damage facilitates DNA repair in an ATP-dependent 
process. Caspase-3 mediated inactivation of PARP by cleavage preserves 
cellular ATP for apoptosis requirement. Absence of PARP leads to unrepairable 
DNA damage promoting ATP-dependent programmed compartmentalization of 
the cellular organelles into apoptotic blebs (Endres et al., 1997; Murphy, 1999; 




Caspase cascade independent apoptosis 
 
 
Programmed cell death independent of caspase is initiated by a 
collective group of proapoptotic proteins released from the mitochondrial 
transition pores, into the cytoplasm. These proteins include and Bcl-
2/adenovirus E1B 19 kDa-interacting protein (BNIP3), apoptosis inducing 
factor (AIF) and endonuclease G. AIF-induced cell death is independent of 
functional caspases serving as an alternative death pathway. Depletion of 
cellular energy which is an unfavorable event for caspase activation can still 
stimulate AIF-mediated cell death (Cregan et al., 2002).  When AIF is truncated 
by calpains and released from the mitochondria to translocate in the nucleus 
causing DNA fragmentation and peripheral nuclear chromatin condensation, 
which is distinct from caspase-dependent chromatin condensation and DNA 
fragmentation. AIF release from mitochondria is mediated by the presence of 
PAR polymers generated by PARP-1 and tBID. Activated AIF inhibits protein 
translation by its association with the translation inhibition factor, eIF3g and its 
translocation to the nucleus is mediated by cytoplasmic peptidyl-prolyl 
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isomerase enzyme, cyclophilinA. Recently, this mechanism is termed, 
programmed necrosis or necroptosis, but whereas it’s widely recognized as 
caspase-independent apoptosis (Daugas et al., 2000; Cregan et al., 2004; 
Culmsee et al., 2005; Cho and Toledo-Pereyra, 2008; Baxter et al., 2014). 
 
 
Endonuclease G nuclear translocation occurs alongside AIF 
translocation and is also associated with fragmenting DNA during cell death 
after ischemic stroke. A proapoptotic member of the Bcl-2 family, BNIP3 
contributes to dysfunction of mitochondria and hence mediates apoptosis 
independent of functional caspases and AIF pathway in neurons following 
stroke. These proteins form the non-canonical pathway different from Cty-
C mediated caspase-dependent intrinsic apoptotic pathway (Lee et al., 2005; 
Zhang et al., 2007; Delavallee et al., 2011). 
 
 
1.3.3b Extrinsic pathway of apoptosis 
 
 
Extrinsic pathway as the name suggests is instigated from the signals 
originated outside the cell. This pathway includes the engagement of the death 
receptors present in the plasma membrane, and thus also referred to as the death 
receptor pathway. The best-characterized death receptors such as, Fas receptor 
(FasR) also termed as cluster of differentiation 95 (CD95) and TNFR-1 also 
referred as p55 or CD120a possesses an important characteristic cytoplasmic 
domain of 80 amino acids long termed ‘death domain’ and extracellular 
cysteine-rich domain. The death receptors sharing these features are grouped 
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together as a family of tumor necrosis factor receptors (TNFR). Besides Fas and 
TNFR-1, the other death receptors of the TNFR family includes, death receptor 
3 (DR3), DR4, DR5 and p75 neurotrophin receptor (p75NTR) also known as 
nerve growth factor receptor (NGFR) (Kenchappa et al., 2010). Characterized 
ligands activating the death receptors belong to the TNF gene superfamily and 
share structurally similar molecules in a homo trimerizing pattern with its 
respective receptors such as, Fas ligand (FasL) activates Fas receptor, tumor 
necrosis factor-α (TNF-α)activates TNFR-1, Apo3 ligand (Apo3L) or TWEAK  
binds DR3, Apo2 ligand (Apo2L) or TRAIL activates DR4 and DR5. The 
receptors when stimulated are conjugated with cytosolic adapter proteins, 
including Fas-associated death domain (FADD), TNFR-associated death 
domain (TRADD), TNFR-associated factor (TRAF), receptor interacting 
protein (RIP) and RIP-associated ICH1/CED3-homologous protein with death 
domain  (RAIDD) or CASP2 and RIPK1 domain containing adaptor with death 
domain (CRADD) (Ashkenazi and Dixit, 1998; Sugawara et al., 2004; Fink and 
Cookson, 2005; Underwood and Coulson, 2008; Broughton et al., 2009; 
Kraemer et al., 2014).  
 
Mechanism of death receptors 
 
 
The mechanism involved in the signaling of Fas and TNFR-1 receptor 
follow a similar pattern. In Fas-mediated apoptosis mechanism, the ligand 
binding to the receptor marks the initiation of the pathway, triggering a cascade 
in the cytoplasm by recruiting adapter protein, Fas-associated death domain 
protein (FADD or called Mort-1). Death effector domain is a classified region 
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of homophilic interaction also termed caspase recruitment domain (CARD). 
Located at the N-terminal of an adapter protein, CARD is the site of initiator 
caspase, procaspase-8 interaction. Together the complex of FasL (Ligand)-Fas 
(death receptor)-FADD (adapter protein)-procaspase-8 (initiator caspase) is a 
death-inducing signaling complex (DISC) and a the state at which procaspase-
8 drives its activation through self-cleavage resulting in cleaved-caspase-8 
(Boldin et al., 1995; Chinnaiyan et al., 1995; Chinnaiyan et al., 1996; Hofmann 
et al., 1997; Vincenz and Dixit, 1997; Muzio et al., 1998). 
 
Procaspase-8 activation mediates cleavage of Bid to genetate truncated 
form of Bid (tBid). tBid integrates with different death pathways at the 
mitochondrial apoptosis checkpoint or activates caspase-3 directly by cleaving 
into its cleaved form. At the mitochondrial membrane tBid interacts with pro-
apoptotic, Bax to dimerize and facilitate the release of Cyt-C, which execute 
conversion of procaspase-9 to its active state, caspase-9 in combination with 
apaf-1. This complex of proteins triggers procaspase-3 dependent PARP 
inactivation and cell death. Alternatively, cleaved-caspase-8 can directly cleave 
procaspase-3 surpassing the mitochondrial route (Vier et al., 1999; Plesnila et 
al., 2001) (Earnshaw, 1995; Le et al., 2002). 
 
Consequently, TNFR-1 mechanism induces apoptosis following ligation 
with the tumor necrosis factor (TNF) ligand. Well established pathways by the 
TNF engaging TNFR1 includes pro-inflammatory signaling mediated by NF-
κB and AP-1 (Roulston et al., 1998). The trimerization of the ligand with the 
receptor induces association of the death domains with the adapter protein 
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TRADD, a platform adaptor enabling the attachment of several molecules 
forming a complex with the death domains of the receptor. The sequential 
molecules include TRAF-2 and RIP triggering the serine-threonine kinase 
enzymatic activity based NF-κB and AP-1 pathway; and FADD recruitment to 
the TNFR death domain complex triggers the apoptosis pathway similar to the 
Fas-mediated apoptosis. TNFR1 is also a site of recruitment for another adapter 
protein called RAIDD/CRADD which binds to the death domain of RIP. These 
adapter proteins in turn interact with the CARD motif of death effector caspase-
2, thereby inducing apoptosis.  (Smith et al., 1994; Gruss and Dower, 1995; Hsu 
et al., 1995; Rothe et al., 1995; Chinnaiyan et al., 1996; Ting et al., 1996; Ahmad 
et al., 1997; Duan and Dixit, 1997).  DR3 is a receptor mimicking TNFR1 
similar mechanism, in response to the Apo3 ligand. DR3 initiates the same order 
of TNFR death domain recruitment of proteins including, TRADD-RIP/TRAF2 
and TRADD-FADD mediated apoptosis.  DR4 and DR5 receptors are activated 
by Apo2L or TRAIL resembling the FasL mediating adapter recruitment for 
apoptosis. Although the p75NTR mechanism is not well studied, the self-
association of its receptor death domain is one of the cell death mechanism 
initiating step (Qu et al., 2013).  
 
Death receptors in cerebral ischemia 
 
 
In stroke, Fas, TNFR-1, p75NTR, DR5 play role in apoptosis in neurons 
activating the downstream executioner caspase, procaspase-3. The expression 
of DR5 death receptors is observed within 12 hours after cerebral ischemic 
formation and is observed to have a sustained activation until 48 hours 
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contributing to the apoptotic death in neuronal cells. A knockout can show a 
93% reduction in the infarct size rescuing the penumbral tissue from demise 
(Rubin et al., 1994).  
 
Figure 4: Extrinsic and Intrinsic apoptotic pathway 
 
Ischemic stroke elicits an acute Ca2+ increase affecting endoplasmic reticulum, 
which releases Ca2+ through a calcium-induced calcium release (CICR) 
mechanism. Accumulated Ca2+ triggers the pro-apoptotic proteins, Bax and Bak 
and permeabilizes mitochondria and mediates release of Cyt-C to form the 
apoptosome complex with Apaf-1 and procaspase-9. This complex activates an 
initiator caspase of intrinsic pathway, procaspase-9 to its cleaved form which in 
turn along with cleaved caspase-8 from the extrinsic pathway cleaves the 
procaspase-3, the executioner caspase to mediate DNA fragmentation. The 
other mitochondrial protein mediating DNA fragmentation is EndoG and AIF 
in its truncated form, tAIF. The truncation of AIF and its release is mediated by 
Ca2+ activated calpains. The mitochondrial permeabilization is also mediated by 
the extrinsic pathway through death receptors mediated activation of Bid to its 
truncated form (t-Bid). Bid activation is regulated by the activated procaspase8, 
an initiator caspase of the extrinsic pathway. Together extrinsic and the intrinsic 
pathway cleave functional proteins and DNA to be assembled into apoptotic 




In sympathetic neurons, P75NTR has an NGF ligand-dependent and oxidative 
stress-mediated mechanism also involving 4-hydroxynonenal (HNE), a lipid 
peroxidation product generated naturally during oxidative stress.  Proteolysis 
of p75 (NTR) by the metalloprotease TNFα-converting enzyme and γ-secretase 
is found necessary for p75(NTR)-mediated apoptotic signaling  (Martin-
Villalba et al., 1999; Harrison et al., 2000; Rosenbaum et al., 2000; Sugawara 
et al., 2004; Angelo et al., 2009; Cui et al., 2010; Kraemer et al., 2014). 
 
1.4 DNA damage and p53 mediated apoptosis in neurons 
 
1.4.1 p53 and post-translational activation 
 
 
p53 mediated apoptosis is an evident mechanism in cell death resulting 
from collective events of cellular insults. The acutest feature integrating various 
neurodegenerative stimuli is oxidative stress and DNA damage which remains 
as the stimulus for p53 transcriptional and non-transcriptional activity 
(Amundson et al., 1998; Lane, 1998). p53 known as a transcription factor for 
decades regulates cell cycle and is an enabled tumor suppressor protein. p53 
transcriptionally regulates genes of p53- regulating control, target genes of cell 
cycle regulation,  involved in angiogenesis controlling genes, genes involved in 
cellular stress response, DNA repair and apoptosis (Amundson et al., 1998; 
Tokino and Nakamura, 2000; Rahman-Roblick et al., 2007). The structure of 
this protein has conserved regions with specialized functions including 1) TAD 
domain, required for transcriptional transactivation at the N-terminal domain 2) 
DNA binding domain which binds to its sequence-specific motif 3) a 
tetramerization domain and regulatory domain near the C-terminal end. 
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Together the C-terminal domain interacts directly with single-stranded DNA 
facilitating transcription (Balagurumoorthy et al., 1995; Joerger and Fersht, 
2010; Saha et al., 2015).  
 
Figure 5: p53 protein domains 
The p53 protein structure briefly divided as N-Terminal domain consisting of 
Transactivation (TAD) and Proline-rich (Pro) domain where the post-
translational modification including phosphorylation occurs to activate the 
protein; N-Terminal is followed by the DNA binding domain specific to its 
binding motif on target genes; C-Terminal domain is the sequence which is 
involved in gene regulation based on the acetylated residues. It consists of 
tetramerization domain (TD) and Regulation domain (RD). 
 
The several stress signals activating p53 are hypoxia, DNA damage, 
radiation or chemotherapeutic drugs. Under ischemic conditions, while the cell 
suffers a collective description of the earlier explained events of cellular 
damage, the resultant DNA breaks, trigger the p53 regulated genes expression 
resulting in functional death proteins (Norbury and Zhivotovsky, 2004). 
Oxidative stress related free radical development and particularly generation of 
highly toxic O2-, OH- ONOO- are the characteristic features of oxidative 
damage mediated DNA breaks. Such DNA breaks are the resultant of highly 
specialised lesions in DNA bases, at the apurinic/apyrimidinic sites (AP sites) 
formed by the hydroxyl radical (OH-) generation (Liu et al., 1996; Lan et al., 
2003; Sugawara and Chan, 2003; Singh and Englander, 2012). Such radicals 
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mediated degradation of proteins involved in cell cycle regulation and DNA 
repair further accumulates excessive DNA breaks which are a characteristic 
feature of ischemic injury and a well-documented stimulus for p53 activation 
shifting the paradigm of the suffering cell towards an apoptotic decision.  
 
Multiple post-translational modifications of p53 are mandatory events 
for defining its function. The orchestrated modifications including 
phosphorylation predominantly at N-terminal residues, poly (ADP) ribosylation 
or acetylation of residues in the C-terminal region either promotes stability of 
the protein or enhances its DNA-binding affinity. These modifications are 
controlled by various kinases emerging in its role by sensing the DNA damage 
and initiate the post-translational modification at site-specific regions largely  
involving serine, threonine, lysine, arginine residues (Malanga et al., 1998; 
Coultas and Strasser, 2000; Appella and Anderson, 2001; Brooks and Gu, 
2003).  Important kinase executing the initial activation of p53 is the ataxia 
telangiectasia mutated (ATM) kinase mediating phosphorylation of p53 at 
serine-15 and serine-20 by acting upstream of p53 upon genotoxic stress (Saito 
et al., 2002). ATM-deficient neurons were partially rescued from excitotoxicity-
mediated neuronal damage illustrating the significance of ATM for p53 
activation (Waterman et al., 1998; Keramaris et al., 2003). Such excitotoxin-
induced apoptosis presented with DNA damage is also controlled by the major 
kinases including mitogen-activated protein kinase (MAPK) family members, 
Jun N-terminal kinase (JNK), and exclusively, the p38 kinase after hypoxia 
downregulates E3 ubiquitin-protein ligase MDM2, a negative regulator of p53, 
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resulting the neuronal accumulation of phosphorylated p53 (Yang et al., 1997; 
Mielke and Herdegen, 2000; Tournier et al., 2000; Zhu et al., 2002).   
MDM2 executes p53 ubiquitination through interaction at the p53 N-
terminal transactivation domain and enhancing p53 nuclear export to be 
degraded by the cytoplasmic proteasome complex. In favor of p53 activity as a 
transcriptional regulator, the inhibition of ubiquitin-dependent degradation of 
the p53 protein is vital. The ubiquitination of p53 is interestingly regulated by 
itself since MDM2 is a p53 transcriptional target. This p53- regulated MDM2 
expression prevails in either a positive or negative feedback loop controlling the 
cellular paradigm towards survival or demise (Lane, 1998; Prives, 1998; Lev 
Bar-Or et al., 2000; Feng et al., 2004). Hypoxia inducible factor-1α (HIF-1α) 
signaling is predominant in early phases of mild hypoxia conditions supporting 
cell survival, however, HIF-1α promotes enhanced p53 transcriptional activity 
towards neuronal death under conditions of sustained hypoxia. HIF-1α is found 
to interact with MDM2 during cellular stress and may indirectly influence 
activation of p53 by inhibiting MDM2 negative regulation over p53. Moreover 
de-phosphorylated HIF-1α stabilizes p53 via interaction to promote cell death 
during hypoxia (An et al., 1998).  
 
 
Further p53 and HIF-1α shares the same co-activator, p300 and by 
competing with HIF-1α, p53 attracts the co-activators while the cellular 
paradigm has to be shifted towards an apoptotic mechanism. Also, p53 
interaction with HIF-1α is enhanced by de-phosphorylation of HIF-1α executed 
during cellular stress and the interaction facilitates the apoptosis pathway. 
(Halterman and Federoff, 1999; Chen et al., 2003a; Greijer and van der Wall, 
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2004; Schmid et al., 2004). These factors primarily lead to phosphorylation of 
p53 at various sites resulting in conformational instability. An offset of the 
conformational instability is governed by a peptidyl-prolyl cis-trans isomerase 
(PPIase), Pin-1 which binds to motifs of phospho-Serine/Threonine-Proline. 
During the phosphorylation of p53, the sites containing these motifs are 
immediately recruited with Pin-1 upon phosphate addition. Such sites include 
Ser 46, Ser 33, Ser 315 and Thr 81 (Zacchi et al., 2002; Sorrentino et al., 2013). 
These regulate the acetylation of p53 by exposing its lysine residues to various 
HATs following the removal of iASPP, an apoptosis inhibitor. The acetylation 
of the protein elicits its transactivation (Mantovani et al., 2007).  
 
 
Some of the immediate response to DNA damage in neurons are elicited 
by PARP-1 mediating DNA repair mechanism and before the apoptotic 
signaling incites. PARP-1 repairs DNA break in an NAD+ dependent manner 
which is derived by utilizing the ATP stores of the cell, resulting as one of the 
factors for bioenergetic failure (Hong et al., 2004). In addition, PARP-1 plays a 
role in poly (ADP) ribosylating p53 protein and promoting its stability by an 
unknown mechanism in neurons undergoing apoptosis. However, some study 
demonstrates loss of binding of poly (ADP) ribosylated p53 to DNA which is 
essential for transactivation of target genes. PARP-1 promoting apoptotic 










1.4.2 p53-mediated transactivation of apoptotic factors 
 
 
After the onset of ischemia, p53 transactivation is instigated to regulate 
target genes including genes regulating its control, target genes involved in 
cellular stress response, DNA repair and apoptosis (Tokino and Nakamura, 
2000; Menendez et al., 2009). The proteins resulting from the p53 triggered 
apoptotic gene regulation widely belong to the Bcl-2 family member consisting 
of the various BH domains such as, BH1, BH2, BH3 or BH4 domain. Regulated 
pro-apoptotic protein  expression includes the multidomain Bcl-2 family 
member Bax, BH3-only members such as p53-upregulated modulator of 
apoptosis (PUMA), Noxa, and Bid plays a key role in specific cases of neuronal 
apoptosis (Rahman-Roblick et al., 2007; Menendez et al., 2009). 
 
Proapoptotic protein, Bax is a key transcriptional target for p53 induced 
by DNA breaks during ischemia and exists as a central mediator of p53-induced 
apoptosis pathway. Triggers during the ischemia such as glutamate and 
oxidative stress are associated with Bax translocation to mitochondrial 
membrane (Xiang et al., 1998; Raghupathi, 2004). At basal condition, Bax is 
inhibited by an anti-apoptotic Bcl-2 family of proteins. The role of Bax in the 
mitochondrial intrinsic apoptotic pathway is the limiting step of mitochondrial 
Cyt-C secretion through the disrupted MTP into the cytoplasm. The release of 
Cyt-C signifies the irreversible apoptotic trigger with the traceable amount of 
apoptosome complex formation consisting Apaf-1, cytochrome-C and 
procaspase-9. As mentioned earlier apoptosome complex indicates the caspase 
cascade initiation to promote apoptosis (Kirkland et al., 2002; Love, 2003). The 
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proapoptotic BH3-only proteins such as Puma and Noxa are also the target 
genes of p53 transcription factor and contributes to cellular infarction by 
functioning as inhibitors of the anti-apoptotic Bcl-2 family proteins by located 
at the mitochondria thus making the pro-apoptotic Bax free to trigger the Cyt-C 
release.  (Vousden and Lu, 2002; Jeffers et al., 2003; Reimertz et al., 2003; 
Webster et al., 2006). 
 
The other target genes of p53 involved in cellular death pathway 
including  Insulin-Like Growth Factor binding protein-3 (IGF-BP3), p53-
activated gene 608 (PAG608), DR5/KILLER, FAS1 and FASL are found to 
play a role in ischemic conditions. IGF-BP3 and PAG608 are observed to be 
up-regulated during ischemia in humans, however, the signaling mechanism is 
not elaborate (Tomasevic et al., 1999; Hermann et al., 2001; Johnsen et al., 
2005).  Genes such as DR5, FAS1 and FASL coding for the proteins involved 
in apoptosis, are associated with the extrinsic pathway.  Dr5 and Fas are well-
characterized receptors widely found in ischemic stroke conditions and FasL 
controls the activation of Fas receptor (Owen-Schaub et al., 1995; Geske et al., 
2001; Reimertz et al., 2003; Culmsee and Mattson, 2005; Webster et al., 2006) 
Other proteins expressed by p53 gene regulation include p53-regulated 
apoptosis inducing protein-1 (p53AIP1), p53-inducible gene (PIG) which are 
related to mitochondrial dysfunction leading to ROS accumulation; protein 
SIVA and its role in ischemia establishing direct interaction with TNFR family 
proteins as well as anti-apoptotic Bcl-2 family proteins is indispensable (Prasad 
et al., 1997; Oda et al., 2000; Matsuda et al., 2002; Xue et al., 2002; Fortin et 
al., 2004).  
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p53 dependent apoptosis in the absence of transcriptional activation of 
p53-target genes is an inevitable mechanism and evidently, occurs in many 
disease models. This mechanism bounds the parallel events during a 
conventional apoptotic pathway.  Mitochondrial translocation of p53 is a 
characteristic non-transcriptional apoptotic function resulting in mitochondrial 
dysfunction and ROS production in response to excitotoxicity, oxidative 
damage of DNA. p53 acquires a non-transcriptional apoptotic role in the 
cytoplasm by carrying out interaction with the anti-apoptotic proteins, Bcl-XL 
and suppressing its effect on mitochondrial membrane stability  (Caelles et al., 
1994; Moll and Zaika, 2001; Gilman et al., 2003; Petros et al., 2004; Endo et 
al., 2006). In addition to anti-apoptotic inhibition process, p53 can mediate 
mitochondrial permeabilization for apoptotic factors through promoting pro-
apoptotic Bcl-2 family members Bax and Bak activity through interaction 

















Figure 6: p53 regulated apoptosis pathway 
At the resting state, p53 is inhibited by MDM2 protein facilitating its 
ubiquitination. During ischemic stroke, the accumulated ROS and Ca2+ ions 
trigger a cascade of events including DNA breaks. DNA breaks activate kinases 
particularly, ATM to phosphorylate p53 resulting in a structural change to 
detach from MDM2. Following, the other residues serine, threonine of p53 gets 
phosphorylated by many cellular pathways including NF-κB, p38, JNK and 
various kinases which are found to be up-regulated by upstream mechanisms 
independent of p53. The different regions of phosphorylation destabilize p53, 
however, the interaction of peptidyl-prolyl isomerase, Pin-1 interaction 
increases p53 stability making it available for HIF-1α regulated stability and 
recruited of co-activator, p300. In addition, the transactivation role of p53 is 
gained by acetylation at the lysine residues found in the C-terminus of the 
protein. The genes transcribed by p53 assumes its role in the apoptosis pathway 
through the extrinsic and intrinsic mechanism. Additionally, p53 has a 
transcription-independent role by inhibiting the anti-apoptotic protein, Bcl-XL 
by interaction, making Bax free for activation and dimerization at the 






1.5 Cell surface receptors in pathogenesis 
 
 
Cell surface receptors are integral proteins activated by external signals 
such as ligand binding which gets transduced into an intracellular signaling 
mediated by various proteins to carry out a specialized biological role. These 
transmembrane proteins  regulates a wide range of pathogenesis including 
reactivity to immune response, cancer, injury, inflammation and cell death 
(Okun et al., 2009; Okun et al., 2011; Pei et al., 2015; Coutaz et al., 2016; Lv et 
al., 2016; Mayer et al., 2016; North, 2016). Widely studied brain ischemic injury 
regulating transmembrane receptors include Pattern recognition receptor 
(PRRs) such as Toll- like receptors, C-type lectin myeloid receptor- Mincle and 
RAGE which promote sterile inflammation following its response to 
endogenous stimuli referred to as "damage associated molecular patterns" 
(DAMPs) (Okun et al., 2010; Kigerl et al., 2014; Okun et al., 2014; Lok et al., 
2015; Arumugam et al., 2016). The other trans-membrane receptors associated 
with stroke are and Notch receptors (Arumugam et al., 2006; Arboleda-
Velasquez et al., 2008; Meng et al., 2015; Zhang et al., 2015; Li et al., 2016).  
 
1.5.1 Notch receptors 
 
 
Notch receptor signaling defines one of the many fundamental cellular 
communication. Notch receptor is a highly conserved trans-membrane protein 
activated through cell-cell interaction to govern the cell fate across various 
species from metazoans to mammalian origin (Kimble et al., 1998; Hurlbut et 
al., 2007). The Notch receptor has diverse function in determining cell fate. The 
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resultant mechanism of Notch is diverse and pleiotropic as both its activation 
and inhibition can regulate cellular events from the developmental stages. Notch 
is involved in the development of the nervous system, including neuronal 
differentiation and glial determination, brain development, stem-cell 
differentiation and termination, cellular proliferation, angiogenesis, cancer 
progression and cell death mechanism. A variety of signaling proteins are 
involved in performing the biological and physiological outcome destined to be 
obtained (Artavanis-Tsakonas et al., 1999; Radtke and Raj, 2003; Bray, 2006).  
The different types of Notch receptor paralogues are identified as Notch1, 
Notch2, Notch3 and Notch4. The biological function of each of these receptors 
have a small degree of overlapping but vary with non-identical expression 
patterns depending on the cellular context and organ type (Hofmann and Iruela-
Arispe, 2007; Greenwald and Kovall, 2013).  
 






The Notch receptor is a single pass transmembrane protein with distinct 
2 regions and 3 cleavable sites. The extracellular domain, the transmembrane 
domain and the intracellular domain with the cleavable sites S1 and S2 at the 
extracellular domain and the S3 cleavable site at the trans-membrane domain 
(Kopan, 2009). During the maturation of the protein, one of the post-
translational modification, O-fucosylation carried out by furin-like convertase 
process the receptor protein by cleaving at the S1 cleavage site in the trans-
Golgi to produce the final structure of the non-covalently associated 
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heterodimer and prepares it to be launched at the cell surface (Sanchez-Irizarry 
et al., 2004; Gordon et al., 2009).  
 
 
The Extra cellular domain structure contains a 36 epidermal growth 
factors (EGF)-like repeat domain, with few domains containing calcium binding 
sites. Subsequent to the EGF-like repeat is the negative regulatory region (NRR) 
(Rebay et al., 1991). The NRR regions contain the three Lin-12-Notch (LNR) 
repeats lying close to the EGF-like repeats and a hydrophobic hetero-
dimerization (HD) domain lying adjacent to the cell membrane. NRR region 
conceals the S2 cleavage site to prevent the ligand-independent activation. S2 
at the NRR gets unfolded and exposed during ligand interaction (Schroeter et 
al., 1998; Sanchez-Irizarry et al., 2004). 
 
 
The next, S3 cleavage site is present at the trans-membrane segment and 
susceptible to be cleaved upon the slicing of the extracellular domain. The 
cleavage at the S3 site liberates the intracellular domain (NICD) into the 
cytoplasm. NICD consists 4 to 5 domains depending on the type of paralogue. 
RAM, ANK-containing seven ankyrin repeats, TAD which is the trans-
activation domain, OPA and PEST are the 5 types of domains (Tamura et al., 
1995; Kelly et al., 2007). TAD domain is present only in Notch1 and Notch2 






Figure 7: Notch Receptor structure before and after maturation 
The structure of Notch receptor before its maturation and after maturation 
through post-translational modification at the trans-Golgi. The ligand 
interacting domain contains 36-EGF like repeats region with cbEGf (brown) 
and non-cbEGF (green) followed by LNR (Lin-12-Notch) repeats lying 
between the EGF repeats and hydrophobic HD (Hetero-dimerization) domain. 
The LNR and HD domain together form the NRR region. The S1 cleavage site 
lies between the ligand-interacting domain and the functional transactivation 
domain. After translation of Notch receptor protein, it undergoes post-
translational modification at the trans-Golgi through furin-like convertase 
cleaving it at the S1 site and making a non-covalently associated heterodimer 
protein before getting launched at the cell surface. After maturation, NRR 
region of the extracellular domain conceals the S1 cleavage site from being 
susceptible to ligand-independent activation. The trans-membrane (TM) 
consists of the S3 site which upon cleavage generates the active intracellular 
Notch domain (NICD). (Adapted : Sanchez-Irizarry et al., 2004) 
 
 
Each domain of NICD contributes to a unique functionality (Gordon et 
al., 2008). RAM and ANK are involved in its interaction with the CSL 
transcription factors to initiate transactivation (Zweifel et al., 2003), whereas 
PEST domain is identified to regulate NICD proteolytic degradation (Weng et 
al., 2004). Studies have supported this identification, by proving deletion of this 
domain promotes faster ubiquitination of NICD (Baik et al., 2015). ANK fold 
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comprises a pair of antiparallel helices, which participates in protein-protein 
interactions (Zweifel et al., 2003). Notch transcription function includes the 
interaction of NICD to the transcription factors CSL and the co-activator 
MAML. NICD and CSL interaction  predominantly takes place at the RAM 
domain (Lubman et al., 2007) and the co-activator, MAML binding to NICD is 
completely ANK domain dependent (Nam et al., 2006).  
 
Figure 8: Structure of Transmembrane and Notch Intracellular domain  
The structure of the trans-membrane encompasses S3 cleavage site which 
embarks the Notch activation step from being catalyzed by γ-secretase enzyme 
complex. Following the trans-membrane region is the 5 domain region of the 
intracellular portion of the receptor (NICD). RAM containing the nuclear 
localization signal helps in its nuclear translocation, followed by 7-Ankyrin 
repeat domain, ANK, TAD which is the transactivation region, OPA and PEST 








Notch signaling is canonically ligand-dependent. Notch ligands alike 
Notch receptors are single-pass transmembrane which belong to the 
Delta/Serrate ligands (DSL) family of proteins identified in Drosophila 
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corresponding with Delta-like/Jagged ligands (DJL) family of proteins in the 
mammalian forms that consists of six mammalian notch ligands including, 
delta-like homologous (DLL)-1, DLL-2, DLL-3, DLL-4 and serrate-like 
homologous JAG-1 and JAG-2 (Artavanis-Tsakonas S, 1995; Love, 2003; 
Kopan, 2009). The ligand-dependent signaling is initiated when the opposing 
cell expressing Notch ligand is in close proximity to potentiate the ligand 
interaction with heterodimer Notch receptor (de Celis and Bray, 1997). 
Interaction of the ligand to the EGF-like repeats of the extracellular domain 
triggers a structural change in the extracellular domain leading to the NRR 
domain to expose the S2 cleavage site for catalyzes by the metalloprotease 
ADAM enzyme (Vardar et al., 2003). The cleaved Notch-ligand complex 
undergoes endocytosis at the membrane surface of the cell expressing the ligand 
(Weinmaster, 2011; Musse et al., 2012). The remaining tethered fragment of the 
heterodomain receptor at the transmembrane region is now susceptible to S3 
cleavage by the γ-secretase complex to liberate the NICD, an active version of 
Notch receptor and hence γ-secretase complex activity embarks the activated 
stated of Notch receptor.  
 
 
NICD translocates to the nucleus to facilitate the formation of 
transcription enabling CSL-MAML-NICD complex interaction. This organized 
transcription enabling complex is initially designed to rescue the target genes 
from a complex of repressor proteins, in order to be transcribed (Schroeter et 
al., 1998; De Strooper, 1999; Tanigaki, 2010; Borggrefe, 2012; De Strooper et 
al., 2012). In addition, the recruitment of Histone acetyltransferase (HAT) and 
chromatin remodeling complexes leads to transcription of target genes such as 
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Hes-1, Hes-5 which are identified with CSL binding sites (Kurooka, 2000; 
Wallberg, 2002).  
 
 
Alternatively, ligands expressed on the same cell surface as the receptor 
can lead to cis-inhibition to circumvent the ligand-receptor trans-interaction 
(Micchelli et al., 1997). The molecular mechanism of the cis-inhibitory process 
is unknown, yet studies reveal the existence of cis-interaction in the similar 
regions on the cell surface where the receptor is also involved in trans-
interaction (de Celis and Bray, 2000). Calcium binding sites containing EGF 
repeats (cbEGF) of a receptor is studied to be rigid near-linear in architecture. 
However, since Notch extracellular domain consists of the N-terminal region 
and C-terminal region without calcium binding sites and rich with EGF-EGF 
repeats along with few cbEGF repeats and thus may make the structure more 
compact and flexible (Morgan et al., 1999; Hambleton et al., 2004). Without 
cis-inhibition mechanism, the facilitation of the cis-interaction of receptor-
ligand may arise from the EGF–EGF tandem domain’s flexible non-linear 






The ligand-mediated Notch signaling is an extensively studied 
mechanism while the other mechanisms of Notch activation does not have a 
widely collected mammalian evidence. The endogenous cellular system is under 
a constant state of Notch receptor production and degradation making it attain 
a constant state of turnover. Various studies from Drosophila, have highlighted 
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the mechanisms through which ligand-independent Notch activation is 
accomplished. Endocytosis and intracellular trafficking play a vital role. The 
drosophila, E3 ubiquitin ligase, Deltex promotes Notch internalization and 
activates Notch by interacting with its ankyrin domain. Deltex facilitates the 
internalization into the late endosome to execute Notch activation (Diederich et 
al., 1994; Hori et al., 2004).  
 
 
Figure 9: Notch ligand-mediated signaling 
The receptor is post-transcriptionally modified at the trans-Golgi by O-fucosylation 
priming the ligand interacting domain and through furin-like convertase acting at the 
S1 site producing a non-covalently bonded heterodimer to be launched at the cell 
surface. The ligand-receptor trans-interaction initiates the S2 cleavage by ADAM 
metalloprotease followed by the S3 cleavage by γ-secretase liberating NICD to 
translocate into the nucleus. The extracellular domain remains intact with ligand and 
gets internalized into the ligand-expressing cell for ubiquitination. In the nucleus NICD 
associates with CSL and MAML, meanwhile, the transcription complex formation 
dissociates the co-repressors from the gene targets. The NICD/CSL/MAML complex 
recruits other chromatin modeling proteins to carry out the transcription of Hes and 
Hey genes. The cis-interaction between the receptor-ligand of the same cell acts as cis-
inhibition making the receptor not available for trans-interaction signaling.  
49 
 
Ligand-independent Notch activation is also buffered by DSL ligands. As 
explained earlier cis-ligand represses the canonical Notch signaling through 
making the receptor not available for trans-interaction (Chillakuri et al., 2012). 
An absence of both cis- and trans-ligands have found to increase ligand-
independent Notch activation activated cell-autonomously. In addition, the 
Drosophila Hif-1α homolog, sima has endosomal Notch activation role through 
interaction in development (Palmer et al., 2014). ADAM protease, an S2 
cleaving protease is found to be active independent of the ligand when present 
in abundance. NRR region of the extracellular domain which conceals the S2 
site from the ADAM protease activity is perturbed by the calcium chelation due 
to the LNR repeats stability is dependent on the Ca2+ ions for bringing stability 
to the NRR region through calcium bridging (Rand et al., 2000; Delwig and 
Rand, 2008). In mammals, the ligand-independent activation is observed in the 
cancer stem cells which is found to regulate the sphingosine-1 phosphate 
receptor (Hirata et al., 2014). These mechanisms are yet to be explored in 
ischemic stroke conditions although the physiological events of ischemic onset 
lead to the calcium chelation in the extracellular region which could be a crucial 
step in mediating Notch activation. Further, the S3 cleavage site in Notch is 
executed by γ-secretase, presenilin containing the enzyme and the function of 
the γ-secretase enzyme is actively dependent on the intracellular calcium sensor 
protein, calsenilin. In an ischemic stroke, the increased level of intracellular 
calcium regulates the Notch activity by promoting calsenilin and presenilin 










Notch role is observed in all phases of brain development and in other 
cellular events in the adult, however, there is growing evidence that Notch may 
also play a contributing role in pathological events including cortical post-
mitotic neurons, dendritic branching and in neural plasticity (Redmond et al., 
2000). 
 
Notch paralogues are associated with ischemic stroke. Focal cerebral 
ischemia in rodents has shown Notch1 receptor activation. Various studies have 
employed γ-secretase inhibitor, DAPT to explore the biological outcome of 
Notch inhibition. During cerebral ischemia-reperfusion in adult mice and rats, 
DAPT has effected a reduced infarct size and better neurological function 
outcome. Interestingly these studies have observed decreased apoptosis in the 
ischemic region of rodent brain subjected to stroke (Li et al., 2016). Moreover, 
ischemic stroke has been associated with Notch2 paralogue. Rac1, a GTPase 
protein found up-regulated during ischemic stroke in mice IR injury was 
identified to regulate Notch2 receptor. An inhibition of Rac1 GTPase decreased 
the Notch2 activation and resulted in the reduced generation of NICD2. The 
protection caused in mice brain neurological function from Rac1 GTPase has 
been reproduced in DAPT studies as well (Meng et al., 2015). Coherently, 
hippocampal neurons have shown to express Notch2 activity after the onset of 
ischemic stroke (Alberi et al., 2010). Additionally, Notch3 and Notch4 types of 
receptors have been recently reported to contribute to ischemic stroke injury in 




By far the widely studied paralogue of Notch receptors is the Notch1 
receptor (Notch). Extensive mechanistic studies have elaborated the 
intracellular pathways associated with Notch activation. Along with 
pharmacological inhibitor studies using DAPT, Notch reduction at the genetic 
level by employing a Notch antisense mice, the similar protective effect was 
able to be obtained in mice subjected to stroke. Further, an improved 
neurological score in conjunction with reduced infarct size was obtained 
(Arumugam et al., 2006). Notch activation has been observed to increase in 
neurons and microglial population during ischemic stroke. And the main 
mechanism shared by both the cell populations is the Nuclear factor-κB (NF-
κB) pathway and serves as one of the factors for mediating cellular death 
mechanism in neuronal cells shortly after ischemic condition and an early 
microglial inflammatory response mediated leukocyte infiltration followed by 
a delayed cellular death in microglial population (Wei et al., 2011; Li et al., 
2012; Marumo et al., 2013; Yuan et al., 2015). In neuronal cells, NF-κB 
pathway endangers neurons through Bcl-2-interacting mediator (Bim) protein. 
Additively, modified NICD with the nuclear export signal (NES) has proven to 
promote more cell death rate compared to the NICD with nuclear localization 




Similarly, a role for Notch/HIF-1 interaction in neuronal cell death has 
also been documented in ischemic stroke (Cheng et al., 2014a). Cell death was 
potentiated by combined overexpression of Notch intracellular domain (NICD) 
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and HIF-1 compared to that seen with expression of either protein alone. The 
early inhibition of HIF-1 reduced neurological deficits and brain infarct 
volume, and additional protection was obtained by combined inhibition of 
Notch-activating -secretase and HIF-1. Notch signaling can modulate 
mitogen-activated protein kinase (MAPK) pathways and regulate inflammation, 
cell death, and cell proliferation (Pallavi et al., 2012; Yamashita et al., 2013; 
Cheng et al., 2014b). Additional molecular entities likely to play an interacting 
role with Notch following stroke is the c-Jun N-terminal kinases (JNK). Studies 
have also demonstrated that the peptidyl-prolyl cis/trans isomerase, Pin1, 
promotes mechanisms associated with Notch-dependent cell death following 
stroke and was found to interact with NICD to increase its stability by 
circumventing FBW7-induced polyubiquitination (Baik et al., 2015). Pin1 is a 
peptidyl-prolyl isomerase family of enzymes and it catalyzes cis/trans 
isomerization of proline bonds preceded by phosphorylated serine or threonine 
residues (pSer/Thr-Pro). The inhibition of Pin1 independently reduces neuronal 
cell death during oxidative stress indicating the pathogenic role of Pin1 (Shen, 







Figure 10: Notch-mediated cell death pathway in neurons 
The ligand-receptor trans-interaction initiates the S2 cleavage by ADAM 
metalloprotease followed by the S3 cleavage by γ-secretase liberating NICD to 
translocate inside the cell. The figure illustrates the various pathways by which 
NICD is identified to regulate cell death. NICD interaction with HIF-1α and Pin 
is found to enhance its molecular capacity to endanger neurons. NICD is found 
to upregulate NF-κB and JNK-cJun signaling. Together NICD modulates DNA 
damage, inflammation and cell death by regulating these pathways. 
 
 




A surplus of evidence suggests that Notch could promote cell death 
under stroke conditions. Role for Notch in the regulation of NF-B-mediated 
cell death and inflammatory signaling pathways (Arumugam et al., 2011; Wei 
et al., 2011), Notch/HIF-1 interaction in neuronal cell death (Cheng et al., 
2014a) and additionally molecular entities including c-Jun N-terminal kinases 
(JNK) and mitogen-activated protein kinase (MAPK) pathways to mediate 
inflammation, cell death, and cell proliferation (Pallavi et al., 2012; Cheng et 
al., 2014b) are well-established. These pathways have an elaborated role in 
activating apoptosis by promoting the phosphorylation of p53 in various other 
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disease conditions (Buschmann et al., 2001; Chen et al., 2003a; Choi et al., 
2011). Collaborative roles of transcription factors such as nuclear factor-κB 
(NF-κB), hypoxia-inducible factor-1 (HIF-1) with p53 have been 
demonstrated in multiple tissues under different conditions (Halterman and 
Federoff, 1999; Ryan et al., 2000). The peptidyl-prolyl cis/trans isomerase, 
Pin1, mechanisms associated with Notch-stability (Baik et al., 2015) is also a 
stabilizing candidate for post-translationally modified p53 under genotoxic 
stress (Zacchi, 2002; Zheng, 2002).  Yet, Notch association with p53 in 
positively regulating cellular death pathway is yet to be established. However, 
it was shown that conditional expression of a constitutively active form of Notch 
in early neural progenitor cells selectively induces extensive apoptosis by 
elevating levels of nuclear p53 and up-regulating transcription of target pro-
apoptotic genes, Bax and Noxa (Yang et al., 2004), the mechanism behind the 
collaborative apoptotic role of Notch and p53 was not elaborated. Hence 
understanding the collaborative role of NICD and p53 in promoting neuronal 
cell death after the onset of ischemia and the mechanisms via which this 
complex can execute ischemic stroke pathophysiology will broaden the 









 1.6 Hypothesis  
 
The current study is hypothesized that activated Notch receptor is a key 
entity in regulating apoptosis by assisting p53 cellular mechanism. As widely 
studied, p53 stabilization by different proteins has found to be a prerequisite for 
activating p53-mediated various cellular functions. This study proposes a 
mechanism of NICD regulated protein level alteration in p53 to drive its 
transcriptional function of genes involved in apoptosis during the ischemic 
cerebral stroke. Additionally, this study also postulates the established stability 
of NICD conferred through Pin1 interaction will be an indispensable molecular 
mechanism to establish NICD/p53 interaction for stabilizing and activating p53 
mediated transcription to result in ischemic neuronal death. A perturbation in 
this mechanism will render both the protein functionally impaired and fail to 
promote neuronal cell death after the onset of cerebral ischemia.  
Aims 
 
 The severity of apoptotic pathway in cerebral ischemia.  
This was achieved by establishing in vitro ischemic conditions at various 
duration to examine the neuronal adversity in ischemia.  
 
 Modulation of Notch activation to determine the effect of Notch on p53 
activation and its transcriptional steadiness. 
This study was achieved through exogenous Notch expression and 
pharmacological inhibition of Notch mechanism during basal and ischemic 




 Hampering p53 cell death pathway to investigate Notch regulation. 
Using pharmacological inhibition of the active sites in p53, the mechanism 
of Notch activation and transcriptional regulation was investigated for 
variation. 
 
 Molecular elaboration of protein-protein interaction. 
The interaction was probed by endogenous pull-down of the complex in 
basal and ischemic condition. Through hindering the endogenous cellular 
ubiquitination and translation mechanism interaction mediated utility was 
explored. 
 
 The synergistic mechanism through inhibitory approaches.  
Established in vitro and in vivo ischemic model were examined for the 
synergistic function of both proteins and the effect on functional outcome 
















MATERIALS & METHODS 





Dissociated neuron-enriched cell cultures of cerebral cortex were 
established from day 16 C57BL/6NTac mouse embryos. Experiments were 
performed in 7-9 days-old cultures. SH-SY5Y and HEK293T were cultured in 
Dulbecco modified Eagle medium (DMEM; Life Technologies) supplemented 
with 10% fetal bovine serum (HyClone Laboratories, GE Healthcare Life 
Sciences) and 1% penicillin/streptomycin (Life Technologies, Thermo Fischer 
Scientific). For transfection experiments, cells were seeded at a density of 
2x105/well onto 6-well plates on the day before transfection. Cells were 
transfected using Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s protocol and then incubated with complete medium for 24 h. 
Cells were transfected with mouse human Myc-NICD, HA-p53, HA-p53/∆N, 
HA-p53/DBD and HA-p53/∆C domain mutant cDNAs vector for ubiquitination 
and immunoprecipitation studies.  
 
2.2 Oxygen-Glucose Deprivation (OGD) 
 
Cultured neurons were incubated in glucose-free Locke’s buffer 
containing 154 mM NaCl, 5.6 mM KCl, 2.3 mM CaCl2, 1 mM MgCl2, 3.6 mM 
NaHCO3, 5 mM HEPES, pH 7.2, supplemented with gentamicin (5 mg/L) in an 
oxygen-free chamber for various time points.  -Secretase inhibitor (GSI), N-
58 
 
[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT), 
(Calbiochem-Merck Millipore) and the p53 inhibitor pifithrin-α (Calbiochem-
Merck Millipore) were dissolved in dimethylsulfoxide (DMSO, Sigma Aldrich) 
and used at final concentrations as indicated in the results section. To observe 
the effect of GSI (DAPT) or p53 inhibitor (PFTα), DMSO-dissolved drugs were 
added to cultures during OGD with the glucose-free Locke’s buffer. Control 




Figure 11: Oxygen-glucose Deprivation chamber 
The chamber employed in ischemic simulation. The two vents is used as inlet and outlet 
for replacing O2 in the chamber with 95% N2+5% Co2. It consists of an air-tight lock to 
avoid gaseous exchange. 
 
 




Protein samples were subjected to sodium dodecyl sulfate–
polyacrylamide (10%) gel electrophoresis using a Tris-SDS-glycine running 
buffer. Gels were then electro-blotted using a transfer apparatus (Bio-Rad) in 
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transfer buffer containing 0.025 mol/L Tris base, 0.15 mol/L glycine, and 20 % 
(v/v) methanol for 1.5 h at 500 mA onto a nitrocellulose membrane (Bio-Rad). 
The membrane was then incubated for 1 h at RT in blocking agent (1 % Fish 
Skin Gelatin – FSG) dissolved in 1x TBST  (Tris-buffered saline-T) constituted 
of 20 mM Tris-HCl, pH 7.5, 137 mM NaCl and 0.2 % Tween-20. The membrane 
was then incubated overnight at 4 °C with primary antibodies including those 
that selectively bind NICD1 (Abcam), NICD-Myc (Roche), P-p53 (Thr81) 
(Bioss), Total p53 (Cell Signaling Technology), Bax (Abcam), Puma (Abcam), 
Bcl-2 (Cell Signaling Technology), P-Pin-1 (Abcam), Pin-1 (Abcam), Hes1 
(Abcam), cleaved caspase-3 (Cell Signaling Technology), Caspase-3 (Cell 
Signaling Technology) and β-actin (Sigma-Aldrich) in 1x TBST. Subsequently, 
the membrane was incubated with secondary antibodies tagged with horseradish 
peroxidase (HRP) against the primary antibody for 1 h at room temperature 
(RT). The membrane was washed with in 1x TBST and incubated in Clarity 
Western ECL (Chemiluminescent enhancer reagent) before scanning using 
Chemidoc Plus (Bio-Rad). Quantification of protein levels was achieved by 
densitometry analysis using Image J software. 
 
 




Coverslips containing cortical neurons subjected to either control or 
OGD conditions were fixed in 4 % buffered paraformaldehyde (PFA) in PBS. 
Fixed cells were permeabilized using 0.1 % Triton-X in PBS at RT for 15 min 
and incubated in blocking solution (1 % BSA and 0.1 % Triton-X in PBS) at 
RT for 1 h before overnight incubation at 4 °C with microtubule-associated 
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protein 2 antibody (MAP2, Millipore) along with primary antibodies that 
selectively bind NICD (Abcam), P-p53 Thr81 (Bioss) diluted in blocking 
solution. Following incubation with primary antibodies, cells were incubated 
with the appropriate Alexa Fluor conjugated secondary antibodies (In-vitrogen, 
Life Technologies, Thermo Fisher Scientific) for 1 h at RT. The nuclei were 
counterstained with DAPI (AbD Serotec) for 10 min at RT. Following 
secondary antibody incubation, coverslips were sealed with Vectashield 
Fluorescent Mounting Medium (Vector Laboratories) on glass slides. For 
immunohistochemistry, frozen cryostat brain sections were obtained from 
animals subjected to either sham surgery or cerebral ischemia-reperfusion (I/R) 
followed by trans-cardiac perfusion with 4% paraformaldehyde. The brain 
sections were processed using 20% sucrose overnight at 4 °C and 30% sucrose 
overnight at 4 °C. The processed sections were mounted using OCT using a 
mold and sectioned as 20μm thickness using cryostat and immunostained with 
primary antibodies against microtubule-associated protein 2 antibody (MAP2, 
Millipore) or primary antibodies that selectively bind NICD (Abcam), P-p53 
Thr81 (Bioss). Images were acquired using an Olympus FluoView FV1000 
confocal laser-scanning inverted microscope (Olympus, Tokyo, Japan) with a 
60X and 100X oil immersion objective.  
 
 




SH-SY5Y cells were transfected with NICD-Myc and HA-p53 (WT, 
∆N, DBD, ∆C). Transfected cells were lysed in PBS (0.1 % Tween-20) after 24 
h and total lysates were centrifuged at 10,000 x g for 10 min at 4 °C. For 
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ubiquitination, SH-SY5Y cells were transiently transfected with NICD-Myc or 
HIS-ubiquitin, and HA-p53 and incubated for 24 h. Subsequently, cells were 
treated with MG132 (10 µg/mL) for 9 h. Cells were lysed in 
radioimmunoprecipitation assay buffer (RIPA) (200 mM NaCl, 50 mM Tris-cl, 
1 % tritonX-100, 0.1 % SDS) and centrifuged at 10,000 x g for 10 min at 4 °C. 
The supernatant was incubated with Protein A/G Sepharose (GE Healthcare) 
beads overnight at 4 °C. The mixture was centrifuged at 2,000 rpm for 3 s and 
then washed 3 times with 1 ml of radioimmunoprecipitation assay buffer. The 
supernatant was discarded, and remaining beads were supplemented with 15 µL 
of 2x sample buffer and then boiled at 95 °C for 10 min. Subsequently, 
immunoprecipitated materials were subjected to immunoblotting with anti-HA, 
anti-Myc, and anti-p53 antibodies. 
 
 




SH-SY5Y cells were transfected with Myc-tagged NICD and p53 or 
HA-tagged p53 (WT, ∆N, DBD, ∆C) for 24 h and then treated with 
cycloheximide (CHX; 40 µg/mL) at various time points. The cells were 
harvested at the indicated times, followed by an immunoblot analysis with anti-
Myc, anti-p53 and anti-HA antibodies. 
 
 




Experiments were carried out on wild-type (WT) C57BL/6NTac mice obtained 
from In Vivos (Singapore). Three-month-old C57BL/6NTac male mice were 
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subjected to transient middle cerebral artery I/R. Briefly, after making a midline 
incision in the neck, the left external carotid and pterygopalatine arteries were 
isolated and ligated with 6-0 silk thread. The peripheral site of the bifurcation 
of the internal carotid artery (ICA) was occluded with a small clip and the 
common carotid artery (CCA) was ligated with 6-0 silk thread. The external 
carotid artery (ECA) was cut, and a 6-0 nylon monofilament with a tip that was 
blunted (0.20–0.22 mm) with a coagulator was inserted into the ECA. After the 
clip at the ICA was removed, the nylon thread was advanced to the origin of the 
middle cerebral artery until light resistance was evident. The nylon thread and 
the CCA ligature were removed after 1 h to initiate reperfusion. In the sham 
group, surgery was performed until the arteries were visualized. Mice were 
administered with either 40 mg/kg of a gamma-secretase (γ-sec) inhibitor (GSI, 
Calbiochem-Merck Millipore), 2 mg/kg of a p53 inhibitor Pifithrin-α (Santa 
Cruz) or vehicle (DMSO) by infusion into the femoral vein 1 h after the start of 
reperfusion. Experimental doses were determined based on previously 
published work by our group and others. The mice were euthanized with 
isoflurane after either 6 h (for protein analysis) or 24 h (for infarct analysis and 
immunostaining) reperfusion. The animals were included in the study if they 
underwent successful MCA occlusion, defined by an 80 % or greater drop in 
cerebral blood flow seen with laser Doppler flowmetry. The animals were 
excluded if insertion of the thread resulted in perforation of the vessel wall 
determined by the presence of sub-arachnoid blood at the scheduled time of 
euthanasia. A total of 81 mice were employed for the animal study including 30 
mice for protein analysis study with each of the 5 groups having N=6 mice; 45 
mice for the Neurological deficit and infarct area study with each of the 5 groups 
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having N=9 mice; 6 mice for immunostaining study with each of the 2 groups 
having N=3 mice.  
 
Figure 12: Middle cerebral artery occlusion method 
Structural diagram of mice Middle Cerebral Artery Occlusion microsurgery        
(Lee et al., 2014). The figues explains the filament insertion path through  the 
carotid arteries and into the cerebral artery. The filament marked in black, is 
introduced inside the left external carotid after an incision through the left 
internal carotid artery until reaching the middle cerebral artery region and 
sutured for until 1hr to subject the mice to ischemia.  
 
 





The functional consequences of I/R injury were evaluated using a five-
point neurological deficit score (0, no deficit; 1, failure to extend right paw; 2, 
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circling to the right; 3, falling to the right; and 4, unable to walk spontaneously) 
and were assessed in a blinded fashion. Brains were immediately removed and 
placed into phosphate buffered saline (PBS, Sigma-Aldrich) at 4 °C for 15 min, 
and four 2-mm coronal sections were made from the olfactory bulb to the 
cerebellum. The brain sections were stained with 2 % 2,3,5-triphenyltetrazolium 
chloride (TTC) in PBS at 37 °C for 15 min. The stained sections were 
photographed and the digitized images used for analysis.  Borders of the infarct 
in the image of each brain slice were outlined and the area quantified (Image J 
software).  To correct for brain swelling, the infarct area was determined by 
subtracting the area of undamaged tissue in the left hemisphere from that of the 
intact contralateral hemisphere. The infarct volume was determined by 
calculating the percentage of infarcted area in each brain slice, and then 
integrating the infarct areas for all slices of each brain.  
 
 




Statistical analysis of all data except the behavioral score data were 
performed using a one-way ANOVA followed by a Bonferroni post hoc test to 
determine between-group differences.  Statistical difference was accepted if 
P<0.05. Neurological behavior scores were analyzed using a non-parametric 
Kruskal–Wallis test and Dunn’s multiple comparison test.  Statistical analyses 








3.1 Neuronal cell death regulated by notch receptor and 
p53 during Ischemic conditions 
 
3.1.1 Neuronal cell death mediated by caspase cascade pathway 
 
 
To investigate the cell death mechanism initiated by ischemic condition, 
the cell death executing protease, procaspase-3 activation mediated either by a 
mitochondrial damage triggered apoptosome formation or alternatively by 
extrinsic apoptotic signaling by cell surface receptors was observed (Culmsee 
and Mattson, 2005).  The activation of procaspase-3 to produce the active form 
of cleaved caspase-3 (Cl.Cas3) signifies a quantitative neuronal death occurring 
during ischemic condition. The level of Cl.Cas3 elevates gradually over a 
different period of ischemic condition having a significant increase from 3hrs 
of OGD until the prolonged duration of 12hrs OGD (Fig. 13 A and B). Obtained 
significance mimics the neuronal cell population suffering the loss of combat 




Figure 13: Apoptotic cell death during in vitro ischemia 
  
In vitro ischemia increases cell death mediated by a caspase-cascade pathway 
in primary cortical neurons. Neurons were subjected to OGD and analyzed for 
apoptotic cell death marker, cleaved-caspase-3. A and B, Representative 
immunoblot and analysis of cleaved-caspase-3 at the indicated time points 
during OGD. β-actin was used as the loading control. Data are represented as 
mean ± S.E.M. n=5 cultures. **P<0.005 and ***P<0.001 compared with 
normal cell culture.  
 




The activation profile of Notch receptor was examined in ischemic 
conditions to determine the contribution of the receptor during ischemic cell 
death. The biological activity of Notch receptor can be triggered within the vista 
of its cleavage by the gamma-secretase enzyme complex (Arumugam et al., 
2006). The elevated cleaving of Notch receptor to produce the notch 
intracellular domain (NICD), its active form signifies the transcriptional 
function of NICD in association with co-activators such as CBF, MAML, CSL. 
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Established evidence of NICD association with other transcription factors like 
HIF-1α and NF-κB plays a role in regulating the expression of target genes 
(Artavanis-Tsakonas et al., 1983; Lathia et al., 2008).  Here, the activation of 
Notch receptor is significant in the early time points of OGD hours (Fig. 14 
Aand B). Activation of Notch receptor is observed with significance in the 
initial hours of ischemic condition depicting the supporting role of NICD in 
neuronal death.  
 
Figure 14: Notch receptor activation during ischemic conditions 
 
In vitro ischemia increases notch receptor activation in primary cortical 
neurons. Neurons were subjected to OGD and analyzed for notch intracellular 
domain to determine the activation of the receptor. A and B, Representative 
immunoblot and analysis of NICD at the indicated time points during OGD. β-
actin was used as the loading control. Data are represented as mean ± S.E.M. 










The cellular diversity of p53 protein comprises a major responsibility as 
an apoptosis initiator by transcribing the target genes responsible for the 
pathway after being activated (Hong et al., 2010). The activation involves major 
sites of phosphorylation and acetylation. One of the major sites of 
phosphorylation where Threonine-81 (Thr-81) residue lies, enhances the 
stability of the protein to be available for co-activators recruitment and acquire 
gene transcription ability (Buschmann et al., 2001). The elevation of the 
phosphorylated p53 occurs in the early time points of ischemia with a 
significance observed in 3hrs and 6hrs of OGD (Fig 15-A and B).  
 
Figure 15:  Apoptotic initiator, p53 activation during ischemic condition 
In vitro ischemia increases p53 activation in primary cortical neurons. Neurons 
were subjected to OGD and analyzed for phosphorylated levels of p53 to 
determine the transcriptional activation of the protein. A-C, Representative 
immunoblots and analysis of Tp53 and P-p53 at the indicated time points during 
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OGD. β-actin was used as the loading control. Data are represented as mean ± 
S.E.M. n=5 cultures. **P<0.005 compared with normal cell culture. 
 
 
3.1.4 p53 mediated apoptosis and mitochondrial permeability  
 
 
p53 mediated apoptosis involves important protein up-regulation 
including, Bax and Puma. Both the proteins regulate the release of apoptotic 
factors such as Cyt-C, AIF from the mitochondrial inter-membrane space. 
Permeabilization of mitochondria is controlled by Bax dimerization (Eskes et 
al., 1998; Gross et al., 1998) which, is promoted by Puma interacting with anti-
apoptotic proteins, that are otherwise found to inhibit the action of Bax via 
interaction (Yee and Vousden, 2008). Investigation in ischemic condition 
mediated death pathway reveals the significant up-regulation of Bax and Puma 
(Fig. 16 A-C) in the early time points of OGD. Bax is also found to show a 
sustained increase. The up-regulation of these proteins signifies intrinsic 
apoptotic signaling being triggered following Notch and p53 activation in the 





Figure 16: p53 mediated intrinsic apoptotic pathway during ischemic 
condition.  
 
In vitro ischemia activates the intrinsic apoptotic proteins in primary cortical 
neurons. Neurons were subjected to OGD and analyzed for apoptotic proteins 
Bax and Puma to determine the cell death pathway. A-C, Representative 
immunoblots and analysis of Bax and Puma at the indicated time points during 
OGD. β-actin was used as the loading control. Data are represented as mean ± 




The other mechanism of apoptosis is caspase-independent mediated by 
apoptosis inducing factor (AIF) fragmenting DNA. AIF is subjected to the 
positive gene regulation controlled by p53 to mediate a caspase-independent 
cell sensitization and is up-regulated significantly during the ischemic 
conditions to initiate a large-scale DNA fragmentation (Culmsee et al., 2005; 
Stambolsky et al., 2006; Cho and Toledo-Pereyra, 2008). Ischemic condition 








Figure 17: AIF regulated during ischemia 
In vitro ischemia triggers AIF-mediated mitochondrial permeabilization of 
apoptotic proteins in primary cortical neurons. Neurons were subjected to OGD 
and analyzed for AIF to determine mitochondrial permeability. A and B, 
Representative immunoblot and analysis of AIF at the indicated time points 
during OGD. β-actin was used as the loading control. Data are represented as 











3.2 NICD and p53 translocate to the nucleus for 
transcriptional activity  
 
 
Both NICD and p53 are transcription factors regulating specific target 
genes. The presence of these proteins in the cytoplasm does not contribute to its 
transcriptional role rather translocation of the proteins in the nucleus determines 
its transcriptional role. After the onset of ischemic condition the translocation 
of P-p53 and NICD can be observed. The rise in the NICD levels and 
translocation was investigated in primary cortical neurons (Fig. 18 A) and 
neuroblastoma SH-SY5Y (Fig. 18 B). Similarly, the activated transcription 
factor, P-p53 levels and translocation was also investigated in primary cortical 













































































































































































































































































































































































































































































































































































































































































































































































































3.3 Notch receptor activation regulates p53 mediated 
cell death pathway   
 
3.3.1 Exogenous NICD expression mediates endogenous p53 




To determine the mechanism of activated Notch receptor in cell death 
pathway NICD over-expressed model was selected. p53 mediated pathway in 
the exogenous NICD expressing groups at basal condition and ischemic 
condition was demonstrated. The over-expression of myc tagged NICD (myc-
NICD) levels were probed in basal and in vitro ischemic conditions (Fig. 20 A). 
The p53 activation levels significantly raised in the myc-NICD expressing 
groups at basal and ischemic condition (Fig. 20 B and C). Consistently, P-p53 
mediated expression of Bax and Puma elevates in the myc-NICD groups 
compared to the endogenous NICD group during basal and ischemic condition. 
A significant rise of Bax and Puma observed in later time of the OGD treatment 
(Fig. 20 B, D and E) signifying the elevated NICD mediates an apoptotic signal 











Figure 20: Exogenous NICD mediates ischemic apoptosis 
NICD overexpression triggers p53-mediated apoptotic cell signaling. HEK 
293T cells were subjected to OGD at the indicated time points and analyzed for 
NICD and p-53 signaling proteins. A, Representative immunoblot of exogenous 
myc tagged NICD over-expressed protein in HEK 293T cells at the indicated 
time points during OGD. B-E, Representative immunoblots and analysis of P-
p53, Bax and Puma in HEK 293T myc tagged NICD-overexpressing cells at the 
indicated time points during OGD. β-actin was used as the loading control. Data 
are represented as mean ± S.E.M. n=3-5 cultures. *P<0.05 and **P<0.005 
compared with wild-type control. 
 
 





Bcl-2 is a protein with the anti-apoptotic role. It executes its mechanism 
by interacting with the apoptotic protein, Bax to inhibit the promotion of 
mitochondrial permeabilization. The Bcl-2 profile is repressed by p53 upon 
cellular insult, liberating the apoptotic protein from Bcl-2 inhibition. 
Interestingly, the myc-NICD expressing population of cells has decreased Bcl-
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2 protein levels at basal and ischemic conditions (Fig. 21 A and B) with a 
significant decrease during the time of OGD 6hrs. This observation correlates 
with the rise of apoptotic proteins observed (Fig. 20 B, D and E) at the same 
time point in the myc-NICD expressing groups denoting the positive control of 




Figure 21: Exogenous NICD expression decreases cellular antiapoptotic 
role during ischemia  
NICD overexpression decrease anti-apoptotic protein levels. HEK 293T cells 
were subjected to OGD at the indicated time points and analyzed for anti-
apoptotic protein, Bcl-2. A and B, Representative immunoblots and analysis of 
Bcl-2 in HEK 293T myc tagged NICD-overexpressing cells at the indicated 
time points during OGD. β-actin was used as the loading control. Data are 






3.4 Inhibiting Notch receptor activation rescues cell 
from p53 signaling-mediated demise 
 
3.4.1 Notch activation regulates -secretase enzyme inhibition 
demonstrated in non-neuronal cells for mechanistic study 
 
3.4.1a secretase enzyme inhibition decreases apoptotic signaling following 
notch receptor cleavage 
 
 
Figure 22: secretase inhibition (GSI) induced decrease Notch receptor 
activation during ischemia 
NICD generation decreases during secretase inhibition (GSI). Cells were 
subjected to OGD at the indicated time point and analyzed for NICD. A and B, 
Representative immunoblot and analysis of NICD in HEK 293T cells treated 
with different concentrations of GSI or vehicle during 3hrs of OGD. β-actin was 
used as the loading control. Data are represented as mean ± S.E.M. n=3-5 
cultures. ***P<0.001 compared with vehicle-treated control. 
 
 
γ-secretase enzyme executes the activation of Notch receptor and the 
inhibition of its enzyme property limits the cleavage of Notch. Using WT HEK 
293T cell lines p53 mediated activity was determined during the inhibition of 
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the Notch-activating enzyme using Gamma-secretase inhibitor, GSI – DAPT 
(3-50 μM) under in vitro ischemic conditions. As expected, 3hrs of OGD 
induced NICD was reduced significantly by GSI – DAPT at 50 μM 
concentration (Fig. 22 A and B). Intriguingly, the OGD-induced increase in P-
p53 was also attenuated by GSI treatment (Fig. 23 A and B). Coherently, p53 
mediated apoptotic proteins Bax and Puma expression in OGD condition were 
significantly down-regulated by GSI treatment (Fig. 23 A, C and D).  
 
 
Figure 23: Notch inhibition suppresses ischemia triggered p53 activation 
and transcription 
p53-mediated apoptotic cell signaling, suppressed by Notch inhibition. Cells 
were subjected to OGD at the indicated time point and analyzed for p53 
signaling proteins. A-D, Representative immunoblots and analysis of P-p53, 
Bax, Puma, in HEK 293T cells treated with different concentrations of GSI or 
vehicle during 3hrs of OGD.  β-actin was used as the loading control. Data are 
represented as mean ± S.E.M. n=3-5 cultures. *P<0.05, **P<0.005 and 








Using WT HEK 293T cell lines p53 mediated activity was determined 
during the inhibition of the Notch-activating enzyme using GSI – DAPT (3-50 
μM) under in vitro ischemic conditions. The anti-apoptotic protein negatively 
regulated by p53 during 3hrs of OGD was found to increase with GSI treatment 
at 50 μM (Fig. 24 A and B).  
 
 
Figure 24: Notch inactivation benefits cellular antiapoptotic role during 
ischemic condition 
Suppression of Notch signaling positively regulates anti-apoptotic property of 
the cell. Cells were subjected to OGD at the indicated time point and analyzed 
for anti-apoptotic protein, Bcl-2. A and B, Representative immunoblots and 
analysis of Bcl-2, in HEK 293T cells treated with different concentrations of 
GSI or vehicle during 3hrs of OGD.  β-actin was used as the loading control. 
Data are represented as mean ± S.E.M. n=3-5 cultures. *P<0.05 and **P<0.005 




3.4.2 Notch activation controlling -secretase enzyme inhibition 
demonstrated in SH-SY5Y neuroblastoma cells  
 
 
γ-secretase enzyme executes the activation of Notch receptor and the 
inhibition of its enzyme property limits the cleavage of Notch. Using 
neuroblastoma SH-SY5Y cell lines p53 mediated activity was determined 
during the inhibition of the Notch-activating enzyme using Gamma-secretase 
inhibitor, GSI – DAPT (10 and 30 μM) under in vitro ischemic conditions. As 
expected, NICD and P-p53 was reduced significantly by GSI – DAPT at 30 μM 
concentration during 3hrs of OGD (Fig. 25 A-C) and 6hrs of OGD (Fig. 25 D-








Figure 25: GSI induced Notch inhibition negatively regulates p53 
activation during ischemia in neuronal secondary cells 
Notch receptor controls the p53 death signaling in secondary cells of neuronal 
origin. The cells were subjected to OGD at the indicated time points and 
analyzed Notch and p53. A-F, Representative immunoblots and analysis of 
NICD and P-p53 in SH-SY5Y culture treated with different concentrations of 
GSI or vehicle during 3hrs (A-C) and 6hrs (D-F) of OGD.  β-actin was used as 
the loading control. Data are represented as mean ± S.E.M. n=3-5 cultures. 
*P<0.05, **P<0.005 and ***P<0.001 compared with vehicle-treated control. 
 
 




To confirm the consistency in the observed findings, p53 mediated cell 
death was determined during the inhibition by Gamma-secretase inhibitor, GSI 
– DAPT (3-30 μM) under in vitro ischemic condition using primary cortical 
neuron cultures. OGD induced cleaved form of executioner caspase-3, as 
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expected, was reduced significantly by GSI – DAPT treatment (Fig. 26 A and 
B) signifying the cellular death promoted by notch activation. 
 
 
Figure 26: Inhibition of executioner caspase activation following ischemia 
by notch inactivation 
Rescue of neuronal cell death during ischemia attained by notch inhibition. The 
cells were subjected to OGD at the indicated time point and analyzed for 
apoptotic-marker. A and B, Representative immunoblot and analysis of 
cleaved-caspase-3 in primary cortical neuron culture treated with different 
concentrations of GSI or vehicle during 3hrs of OGD. β-actin was used as the 
loading control. Data are represented as mean ± S.E.M. n=3-5 cultures. *P<0.05 
and **P<0.005 compared with vehicle-treated control. 
 
 
In addition to demonstrated cell death protein study Notch and p53 
activity was investigated. As expected, the OGD induced increase in Notch 
activation was attenuated by GSI treatment. OGD mediated NICD increase was 





Figure 27: GSI induced decrease of Notch activation during ischemia in 
primary neuronal cells 
GSI decreases the generation of activated notch upon ischemia. The cells were 
subjected to OGD at the indicated time point and analyzed for Notch activation. 
A and B, Representative immunoblot and analysis of NICD in primary cortical 
neuron culture treated with different concentrations of GSI or vehicle during 
3hrs of OGD. β-actin was used as the loading control. Data are represented as 
mean ± S.E.M. n=3-5 cultures. *P<0.05, **P<0.005 and ***P<0.001 compared 
with vehicle-treated control. 
 
Consistently, a coherent inhibition of p53 activity with GSI treatment in 
primary cortical neurons was observed. OGD induced increase in P-p53 was 
attenuated by GSI treatment (Fig. 28 A and B).  p53 regulated apoptotic protein 
Bax expression in 3hrs of OGD condition was also decreased by GSI treatment 





Figure 28: Notch inactivation negatively regulates p53 activation and 
transcriptional role 
Transcriptional role of p53 is regulated by Notch. The cells were subjected to 
OGD at the indicated time point and analyzed for p53 apoptotic signaling 
proteins. A-D, Representative immunoblots and analysis of P-p53, Tp53 and 
Bax in primary cortical neuron culture treated with different concentrations of 
GSI or vehicle during 3hrs of OGD. β-actin was used as the loading control. 
Data are represented as mean ± S.E.M. n=3-5 cultures. *P<0.05, **P<0.005 and 
***P<0.001 compared with vehicle-treated control. 
 
 
3.5 p53 regulates the activation of NICD and its 
transcriptional role 
 
3.5.1 p53 inhibiting compound toxicity screening 
 
 
Subsequently, the effect of p53 on Notch activation was investigated by 
analyzing the expression of NICD in primary cortical neurons during OGD in 
combination with p53 inhibition. Thus the p53 inhibitor Pifithrin-α (PFT) was 
tested initially for toxicity at a concentration ranging from 300 nM - 20 M. 
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Lactate dehydrogenase (LDH) release from primary cortical neurons subjected 
to in vitro ischemia for 6hrs was found to be reduced significantly with the PFT 
treatment (Fig. 29 A) denoting minimal cellular damage.  In consistency to 
minimized cellular insult, 3hrs of OGD induced cell death marker, cleaved-
caspase-3 was reduced with PFT treatment at 20 M (Fig. 29 B and C). 
 
Figure 29: p53 inhibiting compound, Pifithrin-α (PFT) decreases cell 
toxicity during ischemic condition 
Pifithrin-α (PFT) decreases cell toxicity caused by ischemic treatment by 
decreasing p53 activation. The cells were subjected to OGD at the indicated 
time point and analyzed for apoptotic marker and LDH release. A, cell death 
analyzed by detecting LDH released by primary cortical neuron cultures treated 
with different concentration of PFT or vehicle during 6hrs of OGD. B and C, 
Representative immunoblot and analysis of apoptotic marker, cleaved-Caspase-
3 in primary cortical neuronal cultures treated with different concentration of 
PFT or vehicle during 3hrs of OGD. β-actin was used as the loading control. 
Data are represented as mean ± S.E.M. n=3-5 cultures. **P<0.005 and 
***P<0.001 compared with vehicle-treated control. 
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3.5.2 Inhibition of p53 activation negatively regulates notch 
activation and its transcriptional role 
 
 
Effect of p53 inhibition on its activation was established in primary 
cortical neurons during 3hrs of OGD. The p53 inhibitor PFT was treated in 
cultures subjected to OGD and the data indicated the decrease of induced P-p53 
levels during ischemic condition (Fig. 30 A and B). Surprisingly, the Tp53 
levels were found to be decreased as well (Fig. 30 A and C). 
 
Figure 30: Pifithrin-α (PFT) controls p53 expression and activation 
Pifithrin-α (PFT) decreases p53 activation mediated by ischemic treatment. The 
cells were subjected to OGD at the indicated time point and analyzed for p53 
protein. A-C, Representative immunoblots and analysis of P-p53 and Tp53 in 
primary cortical neuronal cultures treated with different concentration of PFT 
or vehicle during 3hrs of OGD. β-actin was used as the loading control. Data 
are represented as mean ± S.E.M. n=3-5 cultures. *P<0.05 and ***P<0.001 





The effect of p53 inhibition indicated that p53 regulates Notch receptor 
activation and thus its transcriptional function. Cultures subjected to OGD and 
PFT treatment indicated the OGD induced Notch activation was attenuated with 
p53 inhibition (Fig. 31 A and B). Coherently, the NICD target, Hes-1 was 
decreased in PFT treatment during 3hrs of OGD condition (Fig. 31 A and C). 
 
 
Figure 31: p53 inactivation decreases notch receptor activity consequently 
its transcriptional role 
p53 mediates notch activation during ischemic treatment. The cells were 
subjected to OGD at the indicated time point and analyzed for notch pathway. 
A-C, Representative immunoblots and analysis of NICD and Hes-1 in primary 
cortical neuronal cultures treated with different concentration of PFT or vehicle 
during 3hrs of OGD. β-actin was used as the loading control. Data are 
represented as mean ± S.E.M. n=3-5 cultures. *P<0.05, **P<0.005 and 






3.6 Interaction of NICD and P-p53 and neuronal nuclear 
co-localization occurs during cellular ischemia 
 
 
To investigate Notch and p53 collaboration at the nuclear level, 
Immunostaining and co-immunoprecipitation were performed in different 
cultures. Immunostaining of NICD (Fig. 32 A, red; Fig. 33 A, green) and P-p53 
(Fig. 32 A, green; Fig. 33 A, red) in cells subjected to OGD confirmed increased 
levels and co-localization of NICD and p53 in the nucleus of neuroblastoma 
SHSY5Y cell lines (Fig. 32 A) and Primary cortical neurons (Fig. 33 A) in 
response to ischemic condition. Co-immunoprecipitation in neuronal cells 
demonstrated NICD and p53 physically interact together in primary cortical 
neurons (Fig. 32 B and C) and in SH-SY5Y cells (Fig. 33 B) under both normal 










Figure 32: Nuclear co-localization and interaction of transcription factors 
NICD and P-p53 in SH-SY5Y neuroblastoma cells 
In vitro ischemia promotes interaction and neuronal nuclear co-localization of 
both transcription factors. The cells were subjected to OGD at the indicated time 
points for immunoprecipitating NICD/p53 complex and for staining NICD and 
P-p53. A, Immunofluorescence staining of SH-SY5Y cultures showing 
confocal images of NICD (Red), P-p53 (Green), and nuclear marker 4’6-
diamidino-2-phenylindol (DAPI) (blue). Both NICD and P-p53 staining are 
increased and co-localized at the indicated OGD time points. Scale bar: 20 µm. 
B and C, Representative immunoblots of NICD and p53 co-





Figure 33: Nuclear co-localization and interaction of transcription factors 
NICD and P-p53 in primary cortical neurons 
 A, Immunofluorescence staining of primary cortical neuron cultures showing 
confocal images of P-p53 (Red), NICD (Green) and nuclear marker 4’6-
diamidino-2-phenylindol (DAPI) (blue). Both NICD and P-p53 staining are 
increased and co-localized at the indicated OGD time points. Scale bar: 20 µm. 
B and C, Representative immunoblots of NICD and p53 co-







3.7 NICD promotes stability of p53  
 
3.7.1 Exogenous NICD regulates stability of the WT-p53  
 
 
To test whether NICD regulates p53 stability, a GFP-tagged NICD-
overexpressed SH-SY5Y cell line was employed, and p53 stability was assessed 
using cycloheximide (CHX) chases.  The data indicated NICD overexpression 
increased endogenous p53 stability in comparison to pcDNA-transfected cells 
over 9 h in the presence of CHX chases (Fig. 34 A and B).  Subsequently, 
exogenous p53 turnover was demonstrated in SH-SY5Y cells transiently 
transfected with NICD-MYC or pcDNA and WTp53-HA. NICD 
overexpression increased exogenous WT p53 stability over 9 h in the presence 






Figure 34: Stability of WTp53 increases in the presence of exogenous 
NICD 
NICD increases the stability of WT-p53. pcDNA and NICD-GFP were 
transiently transfected in SH-SY5Y cells and after 24hrs, the cells were treated 
with 40 ug cycloheximide (CHX) during the indicated time points. A and B, 
Representative immunoblots and analysis showing p53 stabilization in NICD-
GFP overexpressing cells. WTp53-HA and pcDNA or NICD-GFP were 
transiently transfected in SH-SY5Y cells and after 24hrs, the cells were treated 
with 40 ug cycloheximide (CHX) during the indicated time points. C and D, 
Representative immunoblots and analysis showing exogenous WTp53-HA 
stabilization in NICD-MYC overexpressing cells. Statistical analysis were not 








To understand the mechanism involved in NICD regulation of p53 
stability, exogenous mutated p53 turnover was demonstrated in SH-SY5Y cells 
transiently transfected with NICD-MYC or pcDNA and N-terminal deleted p53 
(ΔN)-p53-HA or DNA binding domain (DBD)-p53-HA or C-terminal deleted 
(ΔC)-p53-HA in the presence of CHX chases.  The data indicated that stability 
of the exogenous HA-tagged (ΔN)-p53 (Fig. 35 A and B), (DBD)-p53 (Fig. 35 
C and D) and (ΔC)-p53 (Fig. 35 E and F) were unrestored by NICD 
overexpression, a quality observed in WTp53 stability (Fig. 34 C and D) over 9 







Figure 35: Mutated exogenous p53 stability remains unchanged during  
NICD presence 
NICD fails to improve the stability of exogenous mutated p53-HA. SH-SY5Y 
cells were transiently transfected with ΔNp53-HA, DBDp53-HA, ΔCp53-HA 
and NICD-MYC or pcDNA and after 24hrs, the cells were treated with 40 ug 
cycloheximide (CHX) during the indicated time points. A-F, Representative 
immunoblots and analysis showing the stability of p53 deletion mutants 
following overexpression of NICD-MYC. Statistical analysis were not done due 





NICD promotes WTp53 stability, whereas fails to restore mutant p53 
stability, hence, NICD association with the exogenous WT and mutant p53 was 
demonstrated. Co-immunoprecipitation was performed in SH-SY5Y cells 
transiently transfected with NICD-MYC and WTp53-HA or ΔNp53-HA or 
DBDp53-HA or ΔCp53-HA after 24hrs of transfection. Co-
immunoprecipitation with an anti-HA antibody indicated that NICD interaction 
decreased with ΔNp53-HA, DBD-p53 and ΔCp53-HA groups (Fig. 6A and B) 
signifying the interaction is crucial for p53 stability. 
 
Figure 36: NICD interaction with WT-p53 and mutants 
 
NICD interaction with p53 is facilitated by all p53 domains. SH-SY5Y cells 
were transiently transfected with WTp53-HA, ΔNp53-HA, DBDp53-HA, 
ΔCp53-HA and NICD-MYC or pcDNA and Immunoprecipitation was carried 
out with anti-HA.  A and B, Representative immunoblot and analysis showing 
NICD binding with p53 is decreased in ΔNp53-HA, DBD-p53 and ΔCp53-HA 
domain-deleted mutants compared to WTp53-HA following overexpression of 
NICD-MYC. Statistical analysis were not done due to insufficient N. 
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3.8 NICD/p53 complex reduces p53 ubiquitination 
 
 
p53 protein stability is regulated by MDM2 mediation of the ubiquitin-
proteasome pathway (UPP) (Levine, 1997; Wu and Levine, 1997).  As NICD 
was also found to regulate p53 stability, the effects of NICD on p53 
ubiquitination was demonstrated.  SH-SY5Y cells were transfected with HIS-
tagged ubiquitin (Ub-HIS), MYC-NICD, or HA-p53, and then treated with 26S 
proteasome activity blocker, MG132 for 12hrs.  Co-immunoprecipitation using 
an anti-HA antibody showed that polyubiquitinated p53 was markedly reduced 
by NICD overexpression.  In addition, interaction with E3 ubiquitin-protein 
ligase MDM2 was markedly reduced by NICD overexpression (Fig. 37).  
 
 
Figure 37: NICD/p53 complex 
decreases the binding of p53 with its 
negative regulator MDM2 
mediating reduced ubiquitination of 
p53 
Interaction of NICD-p53 reduces p53 
ubiquitination mediated by its 
negative regulator, MDM2. pcDNA, 
NICD-Myc, Ub-HIS and p53-HA 
were transiently transfected into SH-
SY5Y cells and after 24hrs, the cells 
were treated with proteasomal 
inhibitor MG132 (10 g) for 9hrs. A 
co-immunoprecipitation 
representative blot shows reduced 
p53-polyubiquitination and a reduced 
interaction between p53 and MDM2 




3.9 p53 associates with NICD at the N-Terminus 
ANKYRIN (ANK) domain  
 
Notch intracellular domains include RAM, ANK, TAD, OPA and PEST. 
Using deletion mutants of NICD, regions p53 interaction was sought to be 
identified.  HEK293T cell lines stably expressing Myc-tagged WT NICD or 
individual domain-deleted NICD mutants (WT, ∆RAM, ∆ANK, ∆TAD, ∆OPA, 
or ∆PEST) were established. NICD mutant cells were co-immunoprecipitated 
using anti-Myc antibodies. A reduction in the interaction between NICD and 
p53 was observed in the ANK domain-deleted mutant (Fig. 38).   
 
Figure 38: p53 associates at the N-Terminus ANKYRIN (ANK) domain of 
NICD 
NICD associates with p53 at the N-Terminus ANKYRIN (ANK) domain. HEK 
293T stable over-expressing NICDWT-Myc, NICDΔRAM-Myc, NICDΔANK-
Myc, NICDΔTAD-Myc, NICDΔOPA-Myc and NICDΔPEST-Myc were 
subjected to 3hrs of OGD for immunoprecipitation of NICD/p53 complex. 
Representative immunoblot of p53 immunoprecipitation in WT or deletion 





3.10 p53/Notch synergistically activates apoptosis  
 




To determine whether blockade of Notch activation or p53 individually 
can protect against cell death by reducing the NICD-p53 interaction, -secretase 
inhibitor (GSI) DAPT and PFT (p53 inhibitor) was employed.  The data 
indicated that primary cortical neurons cells treated with either DAPT or PFT 
had lower levels of cell death marker, cleaved-caspase-3, compared to vehicle-
treated cells following 3hrs of OGD (Fig. 39 A and B). 
 
Figure 39: Inhibition of executioner caspase activation following ischemia 
by combined notch and p53 inhibition 
Combined inhibition of p53 and Notch synergistically decreases the apoptosis 
execution through caspase-3 during ischemia. Cells were subjected to OGD at 
the indicated time point and analyzed for apoptotic marker protein. A and B, 
Representative immunoblot of cleaved-Caspase-3 in primary cortical neurons 
treated with GSI (30μM) and/or PFT (20μM) compared with vehicle treatment 
during 3 h of OGD. β-actin was used as the loading control. Data are represented 





3.10.2 p53/Notch initiated cellular death suppressed effectively in 
combined inhibition treatment  
 
 
The combined inhibition treatment was found to decrease the Notch and 
p53 activated apoptotic pathway. The data indicated that primary cortical 
neurons cultures treated with either DAPT or PFT had lower Notch activation 
compared to vehicle-treated cells following 3hrs of OGD (Fig. 40 A and B).  
 
 
Figure 40: Combined notch and p53 inhibition furthermore decreases 
NICD generation following ischemia 
Combined inhibition of p53 and Notch synergistically inhibits Notch activation 
further effectively during ischemic stroke. Cells were subjected to OGD at the 
indicated time point and analyzed for Notch activation. A and B, Representative 
immunoblots of activated NICD in primary cortical neurons treated with GSI 
(30μM) and/or PFT (20μM) compared with vehicle treatment during 3hrs of 
OGD. β-actin was used as the loading control. Data are represented as mean ± 









The combined inhibition treatment was found to decrease p53 activated 
apoptotic pathway. The data indicated that primary cortical neurons cultures 
treated with either DAPT or PFT had lower P-p53 compared to vehicle-treated 
cells following 3hrs of OGD (Fig. 41 A and B). Apoptosis-mediating 
downstream target of activated p53 including Bax, and Puma expression was 
lower in either DAPT or PFT treatment compared to vehicle-treated cells 






Figure 41: Combined notch and p53 inhibition effectively decreases the 
apoptotic pathway than independent inhibition 
Combined inhibition of p53 and Notch synergistically inhibits p53-mediated 
downstream apoptotic signaling and rescues cells from ischemic death. A-D, 
Representative immunoblots of P-p53, Bax, Puma in primary cortical neurons 
treated with GSI (30μM) and/or PFT (20μM) compared with vehicle treatment 
during 3hrs of OGD. β-actin was used as the loading control. Data are 
represented as mean ± S.E.M. n=3-5 cultures. *P<0.05, **P<0.005 and 




3.11 NICD and p53 shows neuronal co-localization in 
ischemic brain hemisphere in vivo  
 
3.11.1 Following stroke the mice ischemic brain hemisphere has 
elevated NICD and p53 expression 
 
 
The expression patterns of NICD and p53 were confirmed in vivo 
following 1hr ischemia and 24hrs reperfusion. In the cerebral cortex of sham-
operated control mice, very little immunoreactivity with NICD and p53 
antibodies was observed, and both NICD and p53 appeared restricted to the 
neuronal cytoplasm (Fig. 42 A and B).  After 24hrs of post-ischemic 
reperfusion, neurons in the ischemic cortex (ipsilateral) exhibited robust NICD 






Figure 42: NICD and p53 expression in ipsilateral region of ischemic 
brain 
NICD and p53 expression elevate in ischemic brain hemisphere of mice 
following ischemic stroke. Mice underwent 1hr MCAO and 24hrs reperfusion 
(I/R). Obtained brain sections were stained. A and B, Immunofluorescence 
staining of ischemic (ipsilateral and contralateral) and sham (ipsilateral) brain 
sections showing confocal images of NICD (A, green), P-p53 (B, green), the 
neuronal marker MAP2 (red), and the nuclear marker 4’6-diamidino-2-




3.11.2 NICD/p53-Pin1 complex presence and NICD and p53 
nuclear co-localization in the ischemic brain   
 
 
The co-localization of NICD and p53 were confirmed in vivo following 
1hr ischemia and 24hrs reperfusion. In the cerebral cortex of sham-operated 
control mice, very little immunoreactivity with NICD and p53 antibodies was 
observed, and both NICD and p53 shows no localization in the nucleus of 
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neurons in the ischemic cortex (Fig. 43 A). After 24hrs of post-ischemic 
reperfusion, neurons in the ischemic cortex (ipsilateral) exhibited robust NICD 
and p53 expression and neuronal nucleus co-localization (Fig. 43 A and B).  
 Furthermore, co-immunoprecipitation was performed in the ipsilateral brain 
tissue from mice subjected to focal ischemic stroke and the findings indicate 
NICD and p53 are a complex (Fig. 43 C and D). A peptidyl-prolyl isomerase, 
Pin1 proven to confer stability to NICD and p53 separately (Zheng, 2002; 
Sorrentino et al., 2013; Baik et al., 2015) was also co-immunoprecipitated with 












Figure 43: NICD and p53 nucleus co-localization and NICD/p53-Pin-1 
complex formation in ipsilateral region of ischemic brain 
NICD and p53 nuclear co-localization and NICD/p53-Pin-1 complex 
interaction in ischemic brain hemisphere of mice following ischemic stroke. 
Mice underwent 1hr MCAO and 24hrs reperfusion (I/R). Obtained brain was 
sectioned and stained or lysed for immunoprecipitation. A and B, 
Immunofluorescence staining of ischemic (ipsilateral and contralateral) and 
sham (ipsilateral) brain sections showing confocal images of NICD (red), P-p53 
(green) and the nuclear marker 4’6-diamidino-2-phenylindol (DAPI) (blue) in 
the cortical neurons of mice brain. Scale bar: 20 µm; *core region. C and D, 
Representative immunoblots of NICD, p53 and Pin-1 co-immunoprecipitation 








3.12 Inhibition of NICD and P-p53 may reduce ischemic 
brain injury in vivo. 
 
3.12.1 Caspase-mediated cell death may decrease during p53 and 
Notch inhibition in MCAO mice 
 
 
Finally, the effect of either combined inhibition or individual inhibition 
of -secretase (using DAPT) and p53 (using PFT) was studied on the degree of 
stroke-induced brain injury in vivo.  Intravenous infusion of either DAPT or 
PFT was administered immediately after ischemia for 6hrs. The elevated protein 
levels of cell death marker, cleaved-caspase-3 appears to be reduced by both 
DAPT and PFT treatment (Fig 44 A and B).   
 
Figure 44: Notch/p53 inhibition could decrease cell death in ischemic mice  
Caspase-activated cellular death is suppressed in the ischemic hemisphere of 
stroke mice during the treated with separate inhibition of p53/NICD proteins. 
Mice underwent 1hr of MCAO and 6hrs reperfusion (I/R) and were analyzed 
for cell death marker. A-B, Representative and quantification of cleaved-
caspase-3 in the ischemic hemisphere of stroke mice treated with either GSI 




3.12.2 Ischemia-mediated apoptotic pathway could be affected 




The effect of either combined inhibition or either individual inhibition 
of -secretase (using DAPT) or p53 (using PFT) was studied on the degree of 
stroke-induced Notch and p53 activation in vivo.  NICD and p53 in the ischemic 
hemisphere at 6hrs of reperfusion indicated that both NICD and P-p53 were 
elevated after stroke and moderately reduced by either DAPT or PFT (Fig. 45 
A and B; Fig. 46 A and B), confirming that DAPT and PFT may exert protection 
very early following cerebral ischemia.  In addition, while we found no 
significant effect of DAPT or PFT on the expression of Hes1 (Fig. 45 A and C), 
Bax, and Puma (Fig. 46 A, C and D) at 6hrs, there were notable reductions in 
these proteins. 
 




Notch activation is suppressed consistent with apoptotic marker in the ischemic 
hemisphere of stroke mice during the treated with separate inhibition of 
p53/NICD proteins. Mice underwent 1hr of MCAO and 6hrs reperfusion (I/R) 
and were analyzed for Notch activation. A-C, Representative and quantification 
of NICD and Hes1 in the ischemic hemisphere of stroke mice treated with either 
GSI (40mg/Kg) or PFT (2mg/Kg). β-actin was used as the loading control. n=6 




Figure 46: Notch and p53 inhibition modulates the apoptosis mediating 
proteins in ischemic mice 
 
Ischemia-mediated apoptotic cellular death is suppressed in the ischemic 
hemisphere of stroke mice during the treated with separate inhibition of 
p53/NICD proteins. Mice underwent 1hr of MCAO and 6hrs reperfusion (I/R) 
and were analyzed for proteins. A-D, Representative and quantification of P-
p53, Bax, Puma in the ischemic hemisphere of stroke mice treated with either 
GSI (40mg/Kg) or PFT (2mg/Kg). β-actin was used as the loading control. n=6 











3.13 Inhibition of NICD/P-p53 reduces ischemic brain 
injury and improves the functional score in vivo  
 
 
Finally, the effect of either combined inhibition or either individual 
inhibition of -secretase (using DAPT) or p53 (using PFT) was studied on the 
degree of stroke-induced brain injury in vivo.  Intravenous infusion of either 
DAPT or PFT alone immediately after ischemia reduced the extent of 
neurological deficit and brain damage compared to vehicle treatment as 
assessed after 24hrs (Fig. 47 A and B).  Interestingly, combined DAPT and PFT 
treatment did not provide greater protection than did administration of the 





Figure 47: Improved Neurological function and reduced infarct volume of 
the drug treated ischemic mice 
Improved neurological function and reduced infarct volume in the ischemic 
mice treated with separate or combined inhibition of p53/NICD proteins. Mice 
underwent 1hr of MCAO and 24hrs reperfusion (I/R) and were analyzed for the 
neurological deficit and infarct volume. Mice treated with GSI (40mg/Kg) (n=9) 
and PFT (2mg/Kg) (n=9), alone or in combination (n=9), exhibited improved 
neurological function and reduced brain injury after stroke, compared to 
vehicle-treated (n=9) mice.  Neurological score and infarct volume were 
measured at 24hrs following reperfusion.  Data are represented as mean ± SEM 












The findings of this study majorly point out the novel attribute of the 
Notch receptor in endangering neurons by p53 mediated apoptosis. Notch 
interaction with p53 is a critical molecular basis for an apoptotic signaling 
leading to compromised neuronal viability after ischemic stroke.  The functional 
role of NICD-p53 interaction in modifying disease outcome the following 
stroke involves the stabilization of p53 and the transcriptional regulation of p53 
and NICD target genes which can execute the cellular demise through an 
extremely methodical-apoptosis pathway.  In addition, p53 inhibition study in 
vitro has revealed that p53 may positively regulate NICD expression at the 
receptor cleaving level. Importantly, this study has demonstrated NICD 
conferred stability to p53 through substantial interaction and arbitrates the 
rescue of p53 from ubiquitination positively regulated by MDM2.   
 
 
Various cell surface receptors including Toll-like receptors, RAGE, 
Mincle having an established role in stroke pathophysiology such as 
inflammation, cytokines secretion and release of pathological cell mediators 
constitutes a pattern of profound effects in neuronal cells similar to their 
function observed with other pathophysiological conditions involving different 
cell types, glial cells and immune cells are to name a few (Lok et al., 2015; 
Arumugam et al., 2016). The peculiarity of Notch receptor signaling is its 
diversified biological role in an organ specific and cell specific manner 
111 
 
executing mechanisms like differentiation and proliferation during 
developmental stages and adulthood (Artavanis-Tsakonas S, 1995; Artavanis-
Tsakonas et al., 1999). During development of CNS, Notch signaling is 
involved in the maintenance of neural progenitors in an undifferentiated state, 
in part by inhibition of neurogenesis (Redmond et al., 2000). Also, Notch 
receptor influences synaptic plasticity, learning, and memory in the adult brain 
(Lathia et al., 2008; Tan et al., 2014).  The activation of the receptor leads to 
NICD nuclear translocation where it attains functions in conjunction with co-
activators such as CBF-1/Su(H)/LAG-1 (CSL) family of DNA-binding proteins 
by recruiting general transcription factors, including CBP/p300 (Schroeter et 
al., 1998; Brou et al., 2000; Miele, 2006).  NICD-mediated transcription induces 
expression of genes such as Hairy-Enhancer of Split (Hes) and Hes-related 
protein (Herp) (Borggrefe and Oswald, 2009; Guruharsha et al., 2012). Notch-
mediated neuronal cell fate determination or other events could be influenced 
not only by its target genes but also by NICD interaction with other proteins, 
such as Nuclear factor- Kappa B (NF-κB) (Cheng et al., 2001; Arumugam et 
al., 2011), HIF-1α  (Mukherjee et al., 2011; Cheng et al., 2014a) and c-Jun 
(Cheng et al., 2014b; Chen et al., 2016).  
 
 
Interestingly, a cellular death mechanism of Notch in focal ischemic 
stroke was supported by studies showing that mice overexpressing Notch1 
antisense (NAS) and normal mice treated with inhibitors of the Notch-activating 
enzyme, γsecretase, exhibit reduced damage to brain cells and improved 
functional outcome (Arumugam et al., 2006; Arumugam et al., 2011; Cheng et 
al., 2014a). Consequently, the mechanisms underlying Notch-mediated neuronal 
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death in ischemic stroke were further investigated. Notch was shown to bind to 
P-p65 and to prolong NF-κB-mediated proinflammatory responses in immune 
cells (Shin et al., 2006).  Notch signaling was also shown to interact with NF-
κB and to endanger neurons after ischemic stroke by modulating NF-κB activity 
(Arumugam et al., 2011; Wei et al., 2011; Li et al., 2012). Accordingly, 
inhibition of γ-secretase protects against ischemic neuronal cell death by 
targeting NF-κB and the pro-death BH3-only protein, Bcl-2-interacting 
mediator of cell death (Bim) (Arumugam et al., 2011; Li et al., 2012). 
Furthermore, inhibitors of γ-secretase reduce activation of NF-κB and 
expression of proinflammatory mediators, resulting in marked attenuation of 
neurotoxic actions of microglia (Wei et al., 2011; Li et al., 2012).   
 
 
It seemed plausible that other death-promoting transcription factors may 
also interact with NICD and contribute to brain injury following stroke, and 
previously shown is that NICD and HIF-1α bind directly to each other to form 
part of a multiprotein transcriptional complex that may include NF-κB and other 
NICD binding partners (Cheng et al., 2014a).  Levels of NF-κB, p-p65, and cell 
death marker, cleaved Caspase-3 were reduced by inhibition of either γ-
secretase/Notch or HIF-1α and combined inhibition during hypoxic conditions 
(Cheng et al., 2014a).  Interestingly, cell death was effectively reduced by 
combined inhibition of γ-secretase/Notch and HIF-1α than separately. 
Transfection with NICD, HIF-1α, or both, increased the level of the 
phosphorylated (p-p65) and non-phosphorylated (p65) forms of the 65 kDa 
subunit of NF-κB under both normal and hypoxic/ischemic conditions (Cheng 
et al., 2014a).  Likewise, HIF-1α inhibition in neuronal cells transfected with 
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either NICD, HIF-1α, or both, resulted in decreased levels of total and P-p65 
under both normal and hypoxic conditions (Cheng et al., 2014a).  Independent 
of NICD, an interaction between HIF-1α and NF-κB was also demonstrated to 
exist in normal and other disease conditions (Wang et al., 2001; Shin et al., 
2006; Arumugam et al., 2011).  Collectively, the evidence described above 




Nuclear factor-Kappa B (NF-κB) is a diversely triggered protein and 
studies have demonstrated its role in inflammation mediating pathway (Yao et 
al., 2013; Simmons et al., 2016) and in mediating survival mechanism in 
Hodgkin's lymphoma cells rescuing them from undergoing apoptosis under 
stress conditions (Bargou et al., 1997). Moreover, NF-κB  has been proven to 
protect against TNF-α stimulated cell death in rodent fibroblasts (Beg and 
Baltimore, 1996). Nevertheless, contrasting studies have elaborated NF-κB  role  
in apoptosis (Ryan et al., 2000). Focal cerebral ischemic damage triggered NF-
κB activation promotes cell death in rodent models, whereas, the NF-κB 
knockout or inhibition of NF-κB activation studies resulted in minimal cell 
injury in neurons (Hickenbottom et al., 1999; Schneider et al., 1999; Gu et al., 
2012). In addition, negatively regulating NF-κB activation in neonates 
decreases hypoxia-mediated p53 neuronal and mitochondrial accumulation in 
neurons (Nakai et al., 1999; Nijboer et al., 2008).  
 
 
Neuronal death mechanisms in ischemia also include documented NICD 
regulation of MAP kinase-mediated JNK-cJun pathway. The γ-secretase 
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inhibition was previously shown to decrease the phosphorylated JNK and cJun 
proteins leading to minimized cellular stress (Cheng et al., 2014b). c-Jun N-
terminal kinase (JNK) is a kinase widely phosphorylating many proteins 
including cJun, a transcriptional factor contributing to cell death (Chen et al., 
2003b). Moreover, JNK targeted phosphorylation of p53 is an essential 
mechanism for p53 stability in the transcriptional role (Buschmann et al., 2001; 
Chen et al., 2003b; Choi et al., 2011; Shi et al., 2014). Active MAPK signaling 
is observed in cells when lacking oxygen and is a core regulatory mechanism 
for p53 phosphorylation in primary cortical neurons subjected to hypoxia 
(Huang et al., 1999; Sanchez-Prieto et al., 2000; Zhu et al., 2002). Although, it 
seems possible for Notch-mediated MAPK signaling to regulate cell death 
through p53, the direct evidence of Notch in accordance with p53 to contribute 
to cell death under ischemic stroke conditions has not been established. Hence 
the current study about the interplay of two proteins p53 and NICD regulating 
cellular apoptosis is essential. The substantial findings of this study represent 
the first evidence that interactions between NICD and p53 are vital for p53 
stabilization and to promote cell death pathway in the brain following ischemic 
stroke.  
 
The Notch-p53 association in apoptosis was previously established in 
early neural progenitor cells by Yang and colleagues (2004), who showed that 
conditional expression of a constitutively active form of Notch1 selectively 
induces extensive apoptosis by elevating levels of nuclear p53 and up-regulating 
transcription of target pro-apoptotic genes, such as Bax and Noxa (Yang et al., 
2004).  p53 is normally maintained at a low level by MDM2-mediated 
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ubiquitination and proteasomal degradation, and  it can be stabilized by various 
cellular stresses (Prives, 1998; Lev Bar-Or et al., 2000). The p53 protein is also 
involved in the cellular response to ischemia.  The severity and the duration of 
hypoxia/ischemia exert very different influences on the activity, level, and 
apoptotic function of p53 (Hubert et al., 2006; Sano et al., 2007).  Early studies 
reported that the total absence of p53 was marginally protective in ischemic 
stroke (Crumrine et al., 1994)   Another study found that a majority of p53-
deficient mice displayed no signs of cell damage following subcutaneous 
injection of  kainic acid compared to the extensive hippocampal cell loss in 
wild-type animals (Morrison et al., 1996). Furthermore, it was shown that 
pifithrin- protected neurons against apoptosis induced by the DNA-damaging 
agents, amyloid beta-peptide and glutamate (Culmsee et al., 2001).  Animals 
treated with pifithrin- displayed less cell death, decreased expression of the 
p53 target gene BAX (Culmsee et al., 2001) and dose-dependently increased the 
number and size of new neurospheres formed following ischemic stroke (Luo 
et al., 2009).  
 
In the present study, a comparable dose of pifithrinwas employed 
and as expecteda similar degree of neuroprotection in ischemic stroke was 
observed. The apoptotic pathway initiated by p53 either regulated extrinsically 
or intrinsically activates procaspase-3 by cleaving at the CARD domain. In the 
current study, ischemic condition results in elevated cleaved-caspase 3 and AIF 
levels defining the caspase-dependent cell death pathway and caspase-
independent DNA fragmentation occurring during in vitro ischemia (Cregan et 
al., 2002). Expectedly, activated p53 regulating apoptotic pathway was also 
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high. p53 executes cell death by mediating the transcription of apoptotic genes 
including Bax, Puma and Noxa. As a transcription factor p53 can be abundantly 
found in the nucleus in parallel to its degree of presence in the cytoplasm as well 
(Caelles et al., 1994; Chipuk et al., 2004). Hence localization studies can define 
the role of p53 elaborately in conjunction with the protein expression study.  
This study has identified the localization of p53 in SH-SY5Y cultures and 
primary cortical neurons in vitro and in neurons of tissue sections from the 
ipsilateral hemisphere of the ischemic stroke mice in vivo where the neurons 
were identified with MAP2 protein, a marker of neuronal cells (Caceres et al., 
1984; Ingvar et al., 1994). Here, the translocation of P-p53 from the cytoplasm 
to nucleus was evidently traced in the neuronal cultures and the immunostained 
tissues after the onset of ischemic stroke followed by 24hrs reperfusion, 
signifying the p53 transcriptional activity is initiated to maneuver programmed 
cell death during ischemia conditions. Following this study Pifithrin-α treatment 
was employed to determine Notch activity at doses showing decreased p53 
activation reduced cleaved-caspase-3. Surprisingly, Notch receptor activity was 
effectively reduced by Pifithrin-α treatment in primary cortical neurons in vitro. 
Due to the lessening in NICD levels, its target, Hes-1 showed minimal 
expression benefitting the outcome of stroke. Hes-1 has been proven to be 
involved in microglial inflammatory mediated pathway exhibiting detrimental 
effects in rat ischemic stroke brain and Hes-1 has been associated with apoptosis 
by regulating Hes-1-PTEN-AKT-mTOR signaling, observed as a novel 
mechanism of cell death (Yuan et al., 2015; Zeng et al., 2016). In the current 
study p53 inactivation has negatively regulated the Hes-1 mediated possible 




Simultaneously, Notch receptor, the pivotal entity of this study is a well-
established co-activator controlling the activity of transcriptional proteins to 
express target genes and has revealed a synchronized molecular emplacement 
with p53. As a transcriptional co-activator, the translocation of Notch-activated 
receptor domain, NICD from the plasma membrane to the nucleus remains 
indispensable. In accordance with the obtained P-p53 results, localization 
studies of NICD have revealed the translocation of the protein to the nucleus 
upon ischemic stress in SH-SY5Y and primary cortical neuron culture in vitro 
as well as in the tissue sections from an ischemic hemisphere of stroke mice in 
vivo. The intriguing section of the evidence is the observed co-localization of 
NICD along with P-p53 in the neuronal nucleus after the onset of stroke. This 
noted co-localization has further been elaborated by immunoprecipitating either 
of the proteins only to confirm the interaction between NICD and p53 in normal 
as well as ischemic conditions. Likewise, the γ–secretase inhibition exhibited 
the similar pattern of reduction in apoptotic pathway proteins, Bax and Puma 
and resulted in a decrease of Notch activation induced P-p53 levels. γ–secretase 
inhibition was demonstrated in various cellular models which ultimately 
displays the reduction of phosphorylation of p53. Importantly, γ–secretase 
inhibition treatment also decreases the cell death by causing less cleaved-
caspase-3 levels.  These results demonstrate that Notch and p53 activation are 
interdependent following ischemia and either of the activation control could 
modulate the survival attribute of stroked neurons. We also observed an additive 
protective effect by combined Notch/p53 inhibition in a cell culture model of in 
vitro ischemic stroke, but such an additive effect was not replicated in the degree 
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of attenuation of infarct size and neurological deficit score in vivo. It is possible 
that this was due to the severity of our ischemic model such that the maximum 
possible protective effect could be obtained with just a single treatment targeting 
either Notch or p53.  
 
Severe hypoxia, induce p53 in HIF-1α-dependent mechanism in 
different cell models. The direct association of HIF-1α with p53 is found to be 
p53 stabilizing prerequisite (An et al., 1998). Further, the post-translational 
modification of HIF-1α determines its role in providing p53 stability, where the 
hypoxia induced HIF-1α de-phosphorylation favors the stability and 
accumulation of p53 through interaction to initiate apoptosis, on the contrary, 
the phosphorylated form of HIF-1α switches the cellular paradigm to survival 
in hypoxic glioma cells, thus acting as a double-edged sword. (Suzuki et al., 
2001).  Concurrently, in similar cellular models, Notch activity is shown to be 
dependent on HIF-1α (Qiang et al., 2012) and the interaction between HIF-1α 
and NICD confers stability for the dynamic activity of NICD (Qiang et al., 2012; 
Hu et al., 2014) and these evidence are in uniformity with the interaction of 
HIF-1α/NICD observed in promoting neuronal cell death during in vitro 
ischemia (Cheng et al., 2014a).    Also, additive studies offer the supportive 
evidence for HIF-1α-mediated p53 stabilization and HIF-1α/p53 synergistic 
regulation of apoptosis during hypoxia (Halterman et al., 1999; Robertson et al., 
2014; Liu et al., 2016).  In the current study, it is evidently proven that the 
stability of p53 in overexpression of exogenous NICD is observed to increase 
the stability of endogenous p53 and exogenous WTp53 in comparison to 
pcDNA-transfected cells. Whereas the exogenous mutant p53 including 
119 
 
deletion of N-terminal, deletion of C-terminal and presence of the only DBD 
abolished the WTp53 stability resulting from exogenous NICD overexpression. 
This reduction in stability is due to the loss of interaction of the mutant p53 with 
NICD. The interaction between NICD and WTp53 was not consistent with p53 
mutants including the DBD only domain, N-terminal domain deletion or C-
terminal domain deletion mutants. 
 
MDM2 which is a negative regulator of p53 (Lev Bar-Or et al., 2000) is 
found in association with HIF-1α. HIF-1α binding of MDM2 may be the 
possible mechanism of HIF-1α mediated stabilization and activation of p53, 
signifying the rescue of p53 from ubiquitination (An et al., 1998; Robertson et 
al., 2014; Liu et al., 2016). Interestingly in this study, it was observed the 
interaction between the E3 ubiquitin-protein ligase MDM2 and p53 was also 
noticeably reduced by NICD overexpression in neuronal cells following 
conditions of in vitro ischemia.  This observation was coherent with the 
markedly reduced polyubiquitinated p53 with the presence of NICD 
overexpression in neuronal cells following conditions of in vitro ischemia. This 
body of new evidence strongly suggests that the NICD-p53 interplay plays 
pivotal role in determining pro-apoptotic signaling in the brain after ischemic 
stroke. In addition to the NICD overexpression-mediated p53 ubiquitination 
rescue, the non-neural cells stably expressing high NICD, experienced an 
increase in an apoptotic pathway mediated cell death. At basal and in vitro 
ischemic conditions, NICD overexpressing cells is found to have high p53 
activation and hence results in increased levels of Bax and Puma promoting the 




Recently report demonstrated an increased NICD ubiquitination in Pin1 
knockout neuronal cells (Baik et al., 2015). Pin1 is a peptidyl-prolyl isomerase 
(PPIase) with an established role to convene stability to post-translationally 
modified protein by catalyzes of the protein isomerization when phosphorylated 
at the peptide bond between pSer/Thr-Pro. Pin1 is associated with the 
pathogenesis of Alzheimer’s disease (Shen et al., 1998; Butterfield et al., 2006; 
Sultana et al., 2007). In addition, Pin1 also plays a crucial role in neuronal death 
following ischemic stroke (Becker and Bonni, 2007; Baik et al., 2015).  
Specifically, the Pin1-FBW7-Notch1 axis compromises neuronal vulnerability 
after ischemic stroke, and neuronal injury can be ameliorated in vitro and in vivo 
by either a Pin1 inhibitor or in Pin1 deficiency (Baik et al., 2015).  Pin1 interacts 
with NICD in the brain to increase its stability after ischemic stroke by 
inhibiting FBW7-mediated polyubiquitination, resulting in facilitation of 
NICD-induced neuronal death.  Notably, a decreased stability of the NICD 
mutants due to the loss of Pin1 interaction is observed along with NICD mutant 
mediated cell death at minimal in comparison with WT NICD expressing 
population of cells. Thus, the coordinated interaction between Pin1/FBW7 and 
NICD, and the well-established function of Notch1 in ischemia-induced 
neuronal damage provides strong evidence that Pin1 regulates neuronal death 
by stabilizing NICD following ischemic stroke (Baik et al., 2015). 
Concurrently, earlier established work has shown that the phosphorylated p53 
at the pSer/Thr-Pro that is induced by stress must form a complex with Pin1 and 
then undergo a conformational change in order to fulfill its biological roles 
associated with apoptotic gene regulation and cellular events through 
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mitochondrial cell death (Buschmann et al., 2001; Zheng et al., 2002; Zheng, 
2002; Becker and Bonni, 2007; Sorrentino et al., 2013). In the current study, the 
provided evidence displays Pin1 interaction with both NICD and p53 following 
ischemic stroke, indicating that Pin1-mediated NICD stability and/or p53 
phosphorylation play a vital role in the pro-apoptotic function of the p53-NICD 
complex. Furthermore, this study indicates that Pin-1 is pull down as a complex 
with p53 and NICD in the ischemic hemisphere of stroke mice brain.  Pin1 
interaction was lost with the deletion of NICD domains, especially presenting 
with a decreased binding of Pin1 to the ANK domain deleted NICD (Baik et al., 
2015). This finding had brought an attention to explore the domain of NICD 
involved with p53 association. Investigated finding shows p53 interaction with 
NICD occurs via the ANK domain under in vitro ischemic condition. This 
finding is noteworthy, as we have previously reported ANK-domain mutant 
cells to exhibit profound protection under ischemic conditions compared to that 
by other NICD domains such as RAM, TAD, OPA, and PEST deleted or in 
wild-type NICD expressing cells (Baik et al., 2015).  Current and previous 
observations imply that the coordinated interactions between Pin1-NICD, 
NICD-p53, NICD-HIF1and NICD-NF-B may each impact the stability of 
the other protein interactions to promote ischemia-induced neuronal cell death.  
The NICD mediated P kinase signaling up-regulation is the additive factors 
in regulating the interaction of NICD/p53 complex signaling mechanism. Thus 
together these proteins as a complex may have added biological roles and hence 
could enumerate novel cellular mechanisms underlying the pathogenesis of the 









Figure 48: Proposed mechanism of ischemic insult executed by Notch 
 
Ischemic stroke increases neuronal calcium influx from the synaptic cleft 
resulting in calcium chelation. The Ca2+ ions dependent LNR repeats of 
extracellular domain of Notch destabilizes allowing ADAM protease activity at 
the S2 site. The cleavage of S2 actively triggers the spontaneous γ-sec S3 
cleavage liberating NICD in the cytosol. Individually, NICD is ubiquitinated, 
however, Pin1 interaction stabilizes and inhibits degradation of NICD. 
Simultaneously, MDM2 mediated p53 ubiquitination is inhibited by a combined 
mechanism of ATM kinase-added phosphate group and NICD/Pin1 complex 
interaction. At this molecular state, p53 is susceptible to various sites of 
phosphorylation by kinases, some of which are found to be mediated by NICD. 
The phosphorylated form of p53 recruits Pin1 at its Ser/Thr-proline-motifs to 
gain a stable conformation, which mobilizes p300 interaction to acquire 
transactivation role following lysine acetylation. As a complex p53/NICD up-
regulate apoptotic genes expression which results in proteins involved in 
intrinsic apoptotic pathway. Whether NICD plays a role in p53 transcription-






LIMITATIONS OF THE STUDY  
 
In the present study, the individual inhibition of the protein activation 
has a reduced effect on the apoptotic proteins and a combined inhibition 
effectively carried out in the in vitro primary cortical mice neurons were not 
reproducible at the similar degree of consistency in the combined drug-treated 
stroke mice. Although a higher number of animals can make a significant 
difference in the effect observed; alternatively, it can be possible that this was 
due to the severity of our ischemic model such that the maximum possible 
protective effect could be obtained with just a single treatment targeting either 
Notch or p53.  
 
Although the interaction studies of the NICD/Pin1-p53 complex of 
proteins revealed the existence of this complex in basal and ischemic conditions, 
the role of its interaction in the basal state has not been addressed in the study.  
However, since p53 transcription ranges across the self-regulating gene, cell 
cycle control gene regulation, cellular stress, DNA breaks and apoptosis, the 
exhibited interaction in the basal state may be a regulatory mechanism for 
stabilizing the activated p53 to carry out its other biological roles. Importantly, 
the factors that determine whether the interplay of NICD-p53 switches to be 
detrimental for neurons following ischemic stroke need further investigation. 
Moreover, the interaction study was performed within a whole cellular protein 
cocktail. The cellular compartment based interaction study will be an evidence 
to elaborate the intricate mechanism contributed by this complex of proteins to 
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the apoptotic pathway in detail. Since p53 is also involved in a transcription-
independent mechanism of apoptosis, effect on this functional aspect of p53 by 
the established NICD/Pin1-p53 complex role remains to be investigated. 
Additionally, the mechanism involved in p53 inhibition-mediated decreased 
NICD generation is yet to be elaborated. As the activation of Notch receptor is 
executed by the γ-secretase enzyme (Kimble et al., 1998), inhibition of p53 may 
regulate Notch activation either by acting at the level of  γ-secretase enzyme 
complex or via an unknown mechanism mediated to suppress Notch activation.  
 
 
Notch-1 signaling is associated with various pathogenesis including UV 
radiation, leukemia and various other cancers (Ellisen et al., 1991; Kimble et 
al., 1998; Kim et al., 2007). The mechanism of notch signaling in this 
pathogenesis are proliferative and contains cancer-promoting feature. On the 
contrary, Notch induces p21 expression to cause cell cycle arrest and triggers 
terminal differentiation of mouse keratinocytes (Rangarajan et al., 2001). This 
multi-signaling role of Notch receptor is cell-specific and carries out its destined 
biological role in specific pathways distinct to each organ. Interestingly some 
studies have elaborated the mechanism of cancer progression involving NICD 
interaction promoted inhibition of p53 transactivation (Kim et al., 2007; El 
Khatib et al., 2013) which is a reversal effect of the finding from this current 
study. Nevertheless, tumor suppressor role of Notch is also evident in certain 
studies without elaborate mechanism (Shou et al., 2001; Nicolas et al., 2003). 
Due to such non-similarity in Notch signaling towards pathogenesis, the 
mechanism reported from this study is unique and predominant in the neuronal 






As discussed earlier from the current study and previously existing 
observations, the coordinated interaction between Pin1-NICD, and NICD-p53, 
NICD-HIF1and NICD- NF-B may each impact the stability of the other 
protein interactions to promote ischemia-induced neuronal cell death.  P 
kinase signaling up-regulation mediated by NICD are the additive factors in 
regulating the interaction of NICD/p53 complex signaling mechanism. It is 
likely that the NICD/p53 complex plays a key functional role by associating 
with the other protein including Pin1, HIF-1which are proven to associate 
with NICD.  
 
 
It is important for the current study to be reproduced in vivo and 
elaborate the mechanisms required to address the limitations. Nevertheless, it is 
plausible for the complex of these multiprotein to transcriptionally regulate 
genes associated with death signaling which ultimately causes apoptosis in the 
brain following ischemic stroke. These observation when well characterized in 
the upcoming projects, can pave a platform for multiple target for treatment and 
ameliorative post-ischemic damage. An identification of such process can be of 
great importance in understanding the molecular mechanisms of stroke 
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Tissue culture media, buffers and reagents 
 
1) Media for Neuroblastoma SH-SY5Y cell line culture  
For preparing 500 ml 
Reagent Volume v/v (%) 
DMEM/F12 media (Gibco) 450 mL  
Heat inactivated FBS (Biowest) 50 mL 10% 
 
2) Media for HEK 293T cell line culture 
For preparing 500 ml 
Reagent Volume v/v (%) 
DMEM (Gibco) 450 mL  
Heat inactivated FBS (Biowest) 50 mL 10% 
 
3) Media for Primary cell culture 
For preparing 500 ml 
Reagent  Volume 
Neurobasal medium (Gibco)  450 mL 
B-27 supplement  10 mL 
HEPES  5 mM 






4) Locke’s Buffer For preparing 1 L 
Reagent  Final concentration 
NaCl  154 mM 
KCl  5.6 mM 
Na2HCO3  3.6 mM 
CaCl2  2.3 mM 
MgCl2  1 mM 
HEPES  5 mM 
HCl  To adjust pH to 7.2 
Gentamicin  5 mg/L 
ddH2O  Top up to 1 L 
 
5) 1x PBST For preparing 1 L 
Reagent  Quantity 
10x PBS  100 mL 
Tween-20  500 μL 
ddH2O  Top up to 1 L 
 
6) 10x TBST For preparing 1 L 
Reagent Quantity Final concentration 
NaCl 80 g 1.5 M 
Tris  24.2 g 200 mM 
HCl To adjust pH to 7.5  
Tween-20 10 mL  




7) 4% PFA For preparing 1 L 
 
Reagent Quantity 
PFA  40g 
ddH2O 500 mL 
1M NAOH 10 mL 
10XPBS 100 mL 
HCl To adjust pH to 7.4 
ddH2O Top up to 1 L 
 
 
8) RIPA Buffer For preparing 1 mL 
 
 
Reagent  Quantity 










9) 2× Laemmli sample buffer For preparing 1 mL 
 
 
Reagent  Quantity 
2xLaemmli (Bio-rad)  950 μL 








10) 10X Towbin-Electro-Blotting buffer (Transfer buffer) 
 
For preparing 1 L 
 
Reagent Quantity 
Tris 30.1 g 
Glycine 144 g 












11) 10X SDS-PAGE Running buffer  
 
For preparing 1 L 
 
Reagent Quantity 
Tris 30.27 g 
Glycine 138.9 g 
SDS 10 g 
ddH2O 1000 mL 
1XRunning Buffer 
ddH2O 















Tris 45.25 g 
ddH2O 200 mL 
HCl To adjust pH to 8.8 
20% SDS Sol in ddH2O 5 mL 








Tris 6.6 g 
ddH2O 75 mL 
HCl To adjust pH to 6.8 
20% SDS Sol in ddH2O 3.75 mL 









ddH2O 17.5 mL 
Lower Tris-HCl, pH 8.8 10 mL 
40% Acrylamide/bis  12.5 mL 
10% Ammonium persulfate 375 μL 
TEMED 32.5 μL 
153 
 
15) Stacking gel For preparing 4 Gels 
 
Reagent Quantity 
ddH2O 11.5 mL 
Upper Tris-HCl, pH 6.8 2 mL 
40% Acrylamide/bis  1.5 mL 
10% Ammonium Persulfate 154 μL 
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